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Abstract 
Silver, owing to its effective antimicrobial properties, has been used against a broad range of 
microorganisms. Silver is now utilized commonly in numerous consumer products, medical devices 
and clinical applications. However, the mechanism of action of the silver is not yet fully established 
and well-understood. In addition, it is also important to understand the biochemical and evolutionary 
pathways that give rise to resistance. Here, we report new genetic determinants for silver resistance 
in E. coli and explore aspects of their mechanism and laboratory evolution.  
Initial exploration of the antimicrobial activity of silver showed that (1) antimicrobial ability of 
silver is time and dose-dependent; (2) Ag ions have much more antibiotic activity than silver 
nanoparticles (AgNPs) and (3) the antimicrobial ability of AgNPs is size-dependent. Further 
selection for resistance genes of E. coli using AgNO3 and AgNPs led to the identification of several 
candidates, including cysD and ycdB, which displayed cross-resistance to Ag ion and AgNPs as well 
as Cu
+
 and Cd
2+
. The genes cysD and ycdB conferred less resistance to metallic Ag(0) under 
anaerobic incubation than aerobic incubation. These results support that Ag
+
 ions are the main toxic 
agents of AgNPs. These novel anti-silver genes also endowed resistance to the antibiotics kanamycin 
and ampicillin; in these experiments, antibacterial synergy between kanamycin and silver, but not 
between ampicillin and silver, was also found. Quantification of oxygen radicals suggest that silver 
ion is bactericidal through production of reactive oxygen species and that silver-resistance genes 
prevent their generation.  
The selected gene ycdB and control gene cueO, both of which led to increased silver resistance, 
encode Tat-dependent proteins, which are transported after folding from cytoplasm to periplasm. 
Chapter 2 focuses on several Tat-containing genes, which also gave more resistance to Ag ion. The 7 
selected Tat sequence genes, including torA, yedY, sufI, ycdO and hybA, were recombinantly 
expressed in various truncated forms, showing that for ycdB and yedY deleting Tat sequences 
impaired export and silver-resistance ability, despite increased expression, but that for other Tat 
genes deleting Tat had little effect on either periplasmic translocation or resistance. In all cases, 
expression of the Tat export sequence alone or with the his-tag in absence of the gene led to 
suppression of resistance. 
Finally, we explored the evolvability of selected genes, such as yeaO, ydgT, iscA and ycdB for silver-
resistance. Evolved mutants of yeaO and ydgT were found that endowed increased resistance to 
silver compared to wildtypes. In these two cases, increased resistance to silver did not lead to 
increased antibiotic resistance. In short, several kinds of anti-silver genes were identified in our 
studies, showing various pathways rendering resistance to silver. Weak resistance functions for some 
genes were evolvable. Our studies provide a deeper insight into    v  ’  m       m                  
the possible resistance pathways in bacteria, which may in some cases lead also to cross-resistance to 
antibiotics.  
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Chapter 1    Introduction 
Silver, has been used effectively if unwittingly against a broad range of microorganisms since 
ancient times. Silver was arguably the most important antimicrobial compound until the introduction 
of antibiotics, after which silver and its compounds lay largely forgotten. However, due to the 
emergence of antibiotic-resistant pathogens, caused by their misuse, and with the steady 
development of nanoscale science, research on silver and its compounds has recently drawn more 
attention.
1
 Silver nanoparticles, as well as various increasingly sophisticated silver-based compounds 
containing ionic silver (Ag
+
) or metallic silver (Ag
0
) exhibiting antimicrobial activity, are once more 
available for numerous applications.
2-5
  
Compared to other metals and their compounds, such as platinum, gold, iron and nickel, silver has 
shown better bactericidal effects.
6
 Many different assays in vitro and in vivo have explored the 
antimicrobial properties, biocompatibility and toxicity of silver, based on many different bacterial 
strains and cell lines.
7
 Meanwhile, with the increased production volume of silver materials, a number 
of recent studies have focused on the environmental transformations of silver materials and their 
potential adverse effects on human health, because many products release silver in the form of 
nanoparticles, aggregates, or soluble ions during use, washing, abrasion, or disposal.
8-10  
Consequently, it is important to understand in detail how silver and its compounds exert their 
toxicity and to understand how bacteria may acquire silver resistance. Various mechanisms for the 
bactericidal activity of silver have been proposed and different preventive strategies have been 
suggested. The mechanism of silver toxicity in microorganisms has been attributed to multiple 
targets. Silver ions can react with electron-donor groups, such as nitrogen, oxygen, or sulfur atoms. 
These electron-donor groups are present in proteins, nucleic acids, DNA or cell membranes of 
bacteria.
11-14
 Silver ions cause the release of potassium ions from bacteria.
15
 In addition, one silver-
resistance plasmid, pMG101, has been isolated from Salmonella, which contains genes that encode 
for a chemiosmotic ATPase efflux pump, and two periplasmic silver-binding proteins.
16 
Although 
these mechanisms of anti-silver and binding between silver and proteins has been explored in 
specific cases, the mechanism of action of silver is not yet fully established nor well-understood.  
The following sections will elucidate in detail on the use of silver as antibacterial agent, antibacterial 
activity of silver, human and environment toxicity of silver and silver resistance mechanisms. 
1. The use of silver as antibacterial agent 
Silver products, as microcidal agents, are common in medical and commercial applications. In 
hospitals, silver products have been extensively used in wards treating burns, where silver 
sulfadiazine and silver impregnated nylon cloth are used as antiseptics.
12,17
 However, it appears that 
the use of silver preparations in burn treatment is rooted in tradition, whereas its actual effectiveness 
has also been questioned and widely criticized.
18
 A topical ointment that contains 1% silver 
sulfadiazine is widely used in order to prevent and treat infections resulting from second or third 
degree burns, marketed as Silvazine or as Flamazine in USA and other countries.
19,20
 Silver 
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sulfadiazine was initially used in creams, but recently this compound has also been incorporated 
directly into bandages used on burned skin surfaces; silver sutures are often used in surgical 
incisions to prevent infections.
21
 Cerium nitrate-silver sulphadiazine (Flammacerium) as a topical 
treatment for cutaneous burns is deemed to reduce the inflammatory response, is claimed to decrease 
bacterial colonization, and provides a firm eschar (scab) for easier wound management.
20
 Use of 
silver sulfadiazine instead of AgNO3 is due to sulfadiazine ligand keeping the Ag(I) in a stable form, 
which is less subject to blackening by reduction.
19
 The silver ion (Ag
+
) is bioactive and in sufficient 
concentration readily kills bacteria in vitro and in vivo.
22
 AgNO3 has been used effectively as a 
biocide on burns but with the undesirable side effect of turning the burned tissue black from reduced 
Ag(0). Many different applications of silver drugs are currently in clinical trials (Figure 1).  
 
Figure 1. Antimicrobial and antiparasitic drugs approved and in clinical trials. Ref 19. 
Silver-impregnated polymers of medical devices such as catheters and heart valves have been used 
widely to prevent the growth of bacterial biofilms.
23-25
 Plastic in-dwelling catheters coated with 
silver compounds are used to retard the formation of microbial biofilms on the catheters and to 
prevent infection by nosocomial bacteria.
24
 Clinical studies suggest that silver-coating urinary 
catheters and endotracheal breathing tubes may reduce the incidence of catheter-related urinary tract 
infections and ventilator-associated pneumonia, respectively.
25
 Bacterial contamination is one of the 
most important complications of other medical implants, such as hip-replacements.
26
 Bacteria on 
implants typically proliferate and cluster in multilayers of exopolysaccharides, known as biofilms, so 
bacteria can resist antimicrobial agents and immune responses.
27
 In order to prevent infection on the 
surface of implant materials a coordination-polymer network based on silver, as a nanostructure 
coating, and an effective antimicrobial agent, has been synthesized and studied.
28 
Silver salts (such as silver nitrate) have also traditionally been administered to the eyes of newborn 
infants to prevent neonatal eye infections.
29
 The use of silver for ophthalmologic treatment was 
widespread and recently extended. A colloidal form of silver was used successfully in the treatment 
of infected corneal ulcers, interstitial keratitis, blepharitis, and dacrocystitis. Amalgams, so-called 
‘   v           ’                u  35% A (0)     50%   (0)                         u         v    
 3 
used to fill dental cavities, though this approach has been largely replaced by other materials due to 
the presence of toxic mercury in the amalgam.
11
 The Ag
+
-released slowly is thought to result in 
antibacterial activity. For example, Silver-zeolite, a hydrated aluminosilicate powder, is a new 
product of considerable interest, which can bind up to 40% of its weight as Ag
+
 and incorporated 
into medical and dental objects.
30
 
The antimicrobial properties of silver make it useful not only in biomedical settings but also in other 
commercial products. Since silver-impregnated bandages are available for infection prevention, it 
was a short step to embedding Ag in fabrics, including sleeping bags and sports socks.
31,32
 This use 
has been proposed as a means of retarding microbial growth for hygiene and eliminating odor from 
sweat. Supermarket surfaces used for meat storage and display are sometimes ‘   v      ’           a 
possibly useful biocide.
11
 Metallic silver-copper-               m         (‘      P     P u ’)     
marketed as an alternative for users who might be allergic to laundry detergents.
11
 
Silver-containing products are still used in water purification systems to control infectious agents 
(for example, Legionella), such as swimming pool water, hospital hot water systems and potable 
water systems.
33
 The Russian MIR space station and the NASA space shuttle used silver to sterilize 
recycled drinking water.
34
 Supermarket home-water purification units in the USA contain silverized 
activated carbon filters and ion-exchange resins (Brita Company).
34 
Silver-copper ions can even 
replace corrosive chlorine to sanitize pools and tanks.
35
 With the development of nanotechnology, 
AgNPs have gained extensive application as an antimicrobial agent in cosmetics
36
 and the food 
industry, as well as for coating home appliances.
34
 For example, the slow-        “       v  ” 
linings of refrigerators, mobile phones, clothes, plasters, and toothbrushes are also marketed and 
advertised.
34
 Silver, as one of many options, can replace toxic chromated copper arsenate to be used 
as a wood preservative. Nanosilver inks and coatings on paper tout their ability as antimicrobial 
agent used in inhibiting the spread of bacterial infection. Silver-based ionic liquids can be used to 
clean up petroleum waste products. Silver has even been used to plate instruments, such as flutes.
 34
 
Table 1. Noble metal concentration in some cosmetics, determined by atomic absorption spectroscopy after 
chemical pulping. The content of platinum was below the detection limit of 15 ppm 
Sample Noble metal con-
centration [ppm] 
Packaging size 
[mL] 
Noble metal per 
package [mg] 
Silver toothpaste   0.1 75 0.0075 
Silver shower gel   2.7 200 0.54 
Silver hand cream 2700 75 202.5 
Silver deodorant (roller) 950 50 mL 47.5 mg 
Gold night cream 2.4 50 mL 0.12 mg 
Platinum anti-wrinkle cream < 15 50 mL < 0.75 mg 
The noble metal contents in some cosmetics have been measured and summarized by atomic 
absorption spectroscopy (AAS; Table 1).
33
 The concentrations of silver were found to cover a range 
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of more than three orders of magnitude. The potential uses of Ag materials is very extensive, and this 
is only a partial list for silver used as the antimicrobial agent.
34
 In summary, use of silver is 
traditionally routed but is being applied increasingly to many new uses.   
2. Antibacterial activity of silver by binding to biomolecules 
 
Figure 2. Antimicrobial effects of Ag
+
. Interaction with membrane proteins and blocking respiration and 
electron transfer; inside the cell, Ag
+
 ions interact with DNA, proteins and induce ROS production. 
The antimicrobial activity of silver compounds has been studied for a long time.
34,35
 Silver cation is a 
soft Lewis acid, which has an affinity to sulfur but also to nitrogen. So there are many possibilities to 
disturb biochemical processes, which make the mechanism of action of silver ion often inconclusive 
(Figure 2). Silver ion can rapidly interact with thiol groups of membrane proteins of microorganisms, 
leading to the formation of an S–Ag coordination bond. This interaction has been suggested to 
prevent respiration and electron transfer, which in turn hampers the induction of successful rescue 
mechanisms.
36-38
 Blocking respiration and electron transfer causes a collapse of the proton motive 
force, which results in de-energizing of the membrane, ultimately leading to cell death.
37-39
 When 
Ag
+  
ions enter the cytoplasm, they are also able to bind to the guanine base (N7 atom) and interfere 
with DNA replication.
4
 Meanwhile, silver ions can interact with other donor atoms, which are 
present as amino, imidazole, phosphate, carboxyl, or thiol groups in DNA or proteins.
5
 Coordination 
of Ag ions can lead to conformational changes and to inactivation of enzymatic functions. The 
activity of silver ions against some bacteria can be neutralized by cysteine and other thiol 
compounds.
40 
 However on the basis of a 1:1 stoichiometry the three basic amino acids arginine, 
lysine, and histidine are the strongest silver ion binders (Table 2).
41 
In general, coordination sites 
present in an amino acid can be classified as three types: (i) the amino nitrogen-donor at the N-
terminus, (ii) the oxygen atoms of the carboxylic group of the C-terminus, and maybe (iii) the 
heteroatom-containing side chains in various possible coordination modes (Figure 3).
42 
For AgNPs, a 
prime pathway realizing its toxic biological activity appears to be  the release of Ag ion, a view 
which is now increasingly accepted. These ion-based toxicity pathways of Ag particles have been 
proposed to function by (i) generating a continuous flux of Ag
+
 bound on substrates or embedded in 
matrices or (ii) transporting active Ag
+
 to susceptive biological targets on cell membranes or within 
cells ensuing particle attachment or endocytosis.
43,44 
The toxic effect of AgNPs against a broad 
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spectrum of bacteria and viruses has been reported.
45-52 
Several studies suggest that the toxicity of 
AgNPs depends on their size, being responsible for their specific physiochemical characteristics. The 
smaller the nanoparticles are, the larger the surface available for interaction is, resulting in a higher 
specific activity.
53,54 
However, the mechanism of how AgNPs exert their toxicity is not yet 
completely known. 
Table 2.     u      E         Δ  °          E        ΔG° (kJ mol−1)         Am    A    −A (I)   m   x   
α-amino acid  ΔHoa ΔGoa α-amino acid ΔHoa ΔGoa 
glycine (Gly)  206.1 170.1 glutamic acid (Glu)  239.9 203.1 
alanine (Ala)  212.8 176.8 tyrosine (Tyr)  239.9 202.3 
valine (Val)  216.1 181.0 asparagine (Asn)  250.8 217.4 
leucine (Leu)  219.5 185.6 tryptophan (Trp)  260.0 221.5 
isoleucine (Ile)  221.1 188.9 methionine (Met)  262.1 219.9 
serine (Ser)  224.5 190.2 glutamine (Gln)  264.2 225.5 
cysteine (Cys)  230.2 194.4 histidine (His)  284.2 249.1 
threonine (Thr)  233.2 199.8 lysine (Lys)  296.8 260.8 
aspartic acid (Asp)  232.4 199.0 arginine (Arg)  336.5 279.8 
proline (Pro)  234.5 199.8 phenylalanine (Phe)  236.2 198.6 
aEstimated from ref 41.      
 
3. Antibacterial activity of silver mediated through oxygen radicals 
All aerobic organisms produce a by-product of aerobic respiration, reactive oxygen species (ROS), 
such as singlet oxygen, hydrogen peroxide, superoxide radical anion, and hydroxyl radical (equation 
1).
41
 ROS are short-lived reactive oxidants which are highly toxic in that they cause damage to 
biomolecules, such as proteins, DNA, RNA and lipids, so protective mechanisms have evolved by 
all organisms.
55
 This protection in bacteria is reflected by the presence of two sensor-regulator 
proteins called SoxR and OxyR. SoxR-mediated induction of transcription upon silver treatment is 
similar to that found upon paraquat-treatment, a known superoxide-radical generator.
56
 Superoxide 
anions can give rise to release of iron from iron-sulfur clusters of the respiratory chain enzymes, 
which in turn can induce the generation of hydroxyl radicals by the Fenton reaction.
57
 Ag
+
-treated 
E.coli cells exhibited detectable increases in hydroxyl radicals compared to untreated cells.
26
 It was 
proposed that Ag binding to the thiol of anti-oxidative enzymes block their activity, preventing  
detoxification of the generated ROS. Furthermore, bacteria grown anaerobically are often less 
sensitive to Ag
+
 ions, which putatively reflects the influence of ROS production on the antibacterial 
activity of Ag
+
.
56,58
 However, the formation of ROS has been reported to have only a negligible 
contribution to the antimicrobial properties of silver compounds in some reports, indicating that 
other factors are at play.
26
  The contribution of ROS formation is discussed controversially not only 
for Ag(I) but also for AgNPs. Nanosilver particles have been reported to produce lipid-oxidizing 
peroxide intermediates after particle attachment to cell membranes during reactive dissolution. 
 6 
However, the mechanism of antimicrobial action of AgNPs themselves, the so-called particle-based 
mechanism,  remains controversial.
59,60 
 
Figure 3. Selection of possible coordination modes between Ag(I) and amino acids. R represents the side 
chain of the amino acid in general, if it does not participate in the silver binding, while X represents the 
coordinating heteroatom present in the side chain. ref 41 
 
4. Human and environment toxicity of silver compounds 
Speciation of silver-The speciation and bioavailability of silver are important for understanding its 
potential risk. Different forms of silver have different degrees of toxicity. Silver, which is soluble in 
water and unattached to any other atoms while in solution, is                “        v  ”. I           
the free silver is the most toxic form. Some silver compounds such as silver sulfide and silver 
thiosulfate discharge ionic silver very slowly because of very low solubility or complexation of the 
silver (KSP (25 °C): Ag2S = 6 × 10
−51 
mol
3 
L
−3
, AgCl = 1.8 × 10
−10
 mol
2
 L
−2
, Ag3PO4 = 8.89 × 10
−17
 
mol
4
 L
−4
). These compounds are much less toxic than silver nitrate to aquatic organisms.  Because of 
its tendency to form almost insoluble compounds in natural waters and sediments, it has been argued 
that it is in practise impossible for bioavailable silver ions to reach sufficiently high concentrations 
to cause toxicity in marine environments. So the chance for organisms to be affected in the long-
term appears to be minimal.
61
 However, it is crucial to precisely measure silver in the environment 
and to determine the form of silver to predict the potential for any adverse effects. 
Toxicity of silver compounds-There has been a sustained battle for more than 100 years between 
supporters of uses of silver-preparations for health and medical benefits and government agencies 
regulating claims and products.
62-64
 However, with the tremendous boost of silver products in wound 
care products, medical devices, textiles, cosmetics and domestic appliances, the issues of safety and 
potential risks for the human body and environment have also become increasingly urgent and 
relevant.  
Silver contact with the human body is mainly through three ways: respiration, inhalation and skin 
absorption. Compared to most heavy metals, silver is better tolerated by the body and it is relatively 
nontoxic to mammalian cells. The amount of silver contacted by most people on a routine bases is 
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very low,  primarily from food and drinking water, but also to a smaller extent from air (1 × 10
−6
 
μ L−1).65 In the literature, only few studies describe in vivo results concerning the cytotoxicity of 
silver.
66
 The most common observable changes upon acute exposure are argyria and argyrosis which 
are related to prolonged exposure to silver compounds, characterized by an irreversible deposition of 
silver selenide and silver sulfide precipitates in the skin and the eyes, respectively. For example, a 
clinical case of argyria was reported following months of eating a silver-containing food 
supplement.
67
 Another curious case relates to systemic argyria in a patient who chewed photographic 
films in the long term after he gave up smoking.
68
 These cases display that the gastrointestinal tract 
is a place where the sparingly soluble silver halides from the photographic film were easily 
mobilized. Silver salt can be reduced within the tissues. This reduction is photoactivated and causes 
the skin to function in a manner similar to photographic film. The year-long application of a nose 
spray containing protein-bound silver also resulted in argyria.
69
 The affected area became bluish-
gray and got worse in the presence of sunlight; however argyria and argyrosis are not life-
threatening and are not related to irreversible tissue damage.
70-72
 
In some reports a chronic inflammatory reaction occurred when patients were treated with a silver-
coated heart-valve even though the silver blood concentration did not  x     22     (22 μ  L−1);73 
other studies described a simple way toward hybrid fluorescent microgels via photoactivated 
synthesis of Ag nano-clusters in the microgel hosts, with good biocompatibility and no cytotoxic 
effects.
74
 It is well-known that silver toxicity is a dose-dependent process, so these contradictory 
results can be attributed to the variation of the silver concentration acting on different cell types.
21,41 
After an overexposure to silver, silver might be absorbed and transported by the bloodstream, 
accumulating in organs and tissues such as liver, skin, kidney, spleen, heart, lung, olfactory bulb, 
corneas, gingival mucous membranes, brain, and testes.
75-77 
Several systemic clinical side effects of 
silver may emerge, such as leucopenia, liver and kidney damage. Reports on the toxic effects of 
silver for nerve tissue, centrally and in the periphery, are rather rare. However, silver has been 
claimed to cause brain damage,
78
 seizure,
79
 and even a persistent vegetative state.
80
 But since the 
severity of tissue damage is dose dependent, low concentration of silver compounds appears to be 
administrable without lethal side effects. Toxic effects of AgNPs have been studied for different in 
vitro and in vivo mammalian systems.
81-83
 Indeed, AgNPs can potentially cause toxic effects at the 
tissue and cellular level, such as inflammation, immune-cell activation, depletion of glutathione 
(GSH) level in association with mitochondrial dysfunction.
84
 Arora et al. confirmed in vitro clear 
signs of oxidative stress and increased lipid peroxidation when human cell lines were exposed to 
AgNPs.
85
 Finally, all of these processes gradually lead to apoptosis.
86
 How exactly AgNPs induce 
cytotoxicity is still not well understood. Moreover, at the level of the whole organism additional 
complexity arises: for example smaller particles not only have a higher toxicity compared to larger 
particles, but they can also pass more easily through                       u               −      or 
the      −              .87 
Maximum concentrations of total silver that have been recorded in selected non-biological materials 
is 2.0 µg/m
3
 in atmospheric dust; 6.0 µg/litre in groundwater near a hazardous waste site; 300 
µg/litre in treated photoprocessing wastewaters; 43 mg/litre in water from certain hot springs; as 
much as 100 mg/kg in crude oils; and 150 mg/kg in some sediments.
2
 It is important to mention that 
only a small part of the total silver in each of these compartments is biologically available. The 
effect of silver on the environment has been discussed in some review articles, but sometimes 
 8 
distinctly different conclusions were reached.
88-92
                       m “      m    ”    “   
problem at    ”. Although silver enters waste-water from a variety of sources, both industrial (e.g. 
photographic and electronic industries) and from consumer products, a recent assessment came to 
the conclusion that currently biocidal uses of silver (including silver nanoparticles, as well as silver 
in other forms, such as ionic silver) make up not more than 15% of the total silver flow into 
wastewater.
93
 In a general way, silver ion possesses less toxicity to freshwater aquatic organisms 
under conditions of low dissolved silver ion concentration and increasing water pH and hardness.
94
  
5. Silver resistance mechanisms 
With the increase in occurrence and number of antibiotic-resistant strains, silver and its compounds 
have been reused as antimicrobial agents after being largely abandoned for about 50 years in 
response to the discovery and development of antibiotics. As an antimicrobial agent, the biggest 
advantage of silver is its presumed multitarget mechanism, so development of resistance in the cell is 
in theory very difficult and is thought to require plenty of mutations.
95
 However, some bacterial 
strains regularly exposed to relatively high concentrations of silver have been discovered that are 
able to grow in this silver-rich environment.
96-99
 The discovery of these silver-resistant strains caused 
an intensified interest in the machinery of silver resistance. Despite several reports on silver 
resistance in bacteria and the description of several silver-resistant plasmids,
16,100-102
 the molecular 
mechanisms behind the silver resistance remains incompletely understood and two leading theories 
are currently debated: The first one is the accumulation and storage of silver, involving reduction of 
toxic silver ion to less harmful Ag(0),
103
 and the second one is a silver efflux mechanism, silver ion 
being transported out of the bacteria.
104
 These two theories are both based on the concept of 
detoxification of the cell.
105
 The anti-silver plasmid pMG101 is the most extensively studied and 
most frequently cited model.
16,106 
The first proposed mechanism, accumulation and storage-based mechanism, is largely based on the 
silver resistant P. stutzeri strain AG259, which was discovered from silver mines and analyzed by 
Haefeli et al. in 1984.
106
 This kind of strain had the unique capability to reduce Ag
+
 ions into Ag 
nanoparticles and accumulate them within its cell. Ionic silver (Ag
+
) is well-known to be toxic to 
bacteria, so this strain minimizes the Ag ion toxicity by reduction to metallic silver. Notably, in the 
particular context of Ag nanoparticles bio-synthesis by bacteria also opened up new exciting avenues 
for eco-friendly, large-scale, and economically viable shape-controlled synthesis of nanomaterials.
107
 
The pKK1 plasmid was confirmed to encode for Ag-resistance in P. stutzeri strain AG259.
100
 The 
Ag-resistant (AG259) and the Ag-sensitive (JM303) P. stutzeri strains were both able to accumulate 
silver, but TEM and energy dispersive X-ray analysis showed that only the resistant strain was able 
to form dense metal deposits.
108,109
 This is possibly because of high sulfur content which was found 
in the resistant strain AG259. The production of hydrogen sulfide was deemed to play a role in the 
formation of metal deposits. The bio-synthesis of nanosized crystals of diverse types and shapes 
were also reported by using the same silver-resistant strain, indicating that small changes in the 
experimental conditions might have a powerful impact on the outcome of the experiment.
107
 
Acinetobacter baumannii BL88 was also found to accumulate and retain silver. Its plasmid pUIP199 
was discussed to be responsible for the accumulation of silver ions and that silver resistance from the 
plasmid was transferable from Acinetobacter baumannii to E. coli. However, the exact location of 
accumulation of silver, either on the surface of the cell or in its interior, was unclear.
101
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The second mechanism of silver resistance, first postulated by Silver et al. in 1999, involves the 
existence of efflux systems. Plasmid pMG101 is a 180-kb IncH1 silver resistance plasmid
120
 that 
also endows resistance to several antibiotics and other heavy metals, such as mercury and tellurite.
121
 
Research into this plasmid revealed that the silver resistance is encoded by the sil gene cluster 
(Figure 4). This resistance system consists of two Ag(I)-binding proteins (SilE and SilF) and two 
different efflux pumps, a P-type ATPase (SilP) and a membrane potential-dependent three-
polypeptide cation/proton antiporter (SilCBA) (Figure 6). These sil-proteins are only expressed 
when cells are grown in the presence of silver, and their expression is regulated by a system 
consisting of a membrane kinase sensor SilS and a transcriptional regulatory responder, SilR.  
 
 
Figure 4. Silver resistance genes, transcripts and protein products. A: Top line shows the mRNAs. The open 
boxes indicate di¡erent genes or ORFs and their orientations. Nucleotides (nt) between genes and the sizes of 
gene products in amino acids (aa) are marked. B: The proposed function of each gene product, deduced from 
homologies to known proteins (from [17] ) 
SilE and SilF are both thought to bind silver, but they differ in their composition and mode of 
action.
122
 SilE is a small periplasmic Ag(I)-binding protein and combines to Ag(I) ions specifically 
at the cell surface, rendering the first line of resistance against Ag(I) toxicity. SilE contains 143 
amino acids and is 47% identical to the metal binding peptide PcoE from the plasmid copper 
resistance system of E. coli.
16
 SilE has a higher specificity for Ag(I) than Cu(II) and Cd(II).
17
 In SilE, 
10 histidine residues are located as the primary silver binding sites. Binding of Ag(I) to the SilE 
 10 
protein is considered to result in a structural change in protein folding from a random coil to a 
     m      y α-helical system. Compared to other metal-binding proteins such as metallothionein, 
SilE has no cysteine residues (Figure 5).  
The second silver binding protein SilF encoded in the sil system is a homologue of the 
chromosomally-located sequences CusF in E. coli (50% identity). CusF is part of the Cus efflux 
system that gene cluster is mainly involved in copper resistance, and it was proved to also confer a 
certain degree of    v              v     “m            u    ”.      m            m            u      
proposed to act as a metallochaperone. In contrast to other known metal carrier proteins, CusF 
functions as a monomer in which three amino acids (Met47, Met49, His36) fully coordinate Ag(I), 
and Trp44 caps the metal binding site of the molecule.
123,124
 CusF possesses high binding affinity for 
Ag(I) over for Cu(I). This may be attributed to the different affinities of those ions to sulfur ligands 
or to their different sizes. In the sequence of SilF the four amino acids forming the principal binding 
motif are conserved. Consequently, SilF is predicted to bind the silver cation by a single histidine 
        m               u      m   β -sheet structure, similar to CusF. In the current models, both 
metal binding proteins CusF and SilF are in charge of the capture and subsequent transport of Ag(I) 
to the corresponding efflux pumps, where the toxic metal ion is finally eliminated from the cell. 
 
Figure 5. Model for Ag(I) binding and folding of the periplasmic Ag(I)-binding protein SilE. Top: 122-amino 
acid processed SilE protein after removal of 20-amino acid leader sequence with positions of the 10 histidine 
residues noted. Bottom: secondary structure predictions of K-helical (coils) and L-sheet (arrows) regions from 
standard software and predicted cross-linking of five Ag(I) cations by 10 histidines ( from[17] ). 
The silver resistance determinant, SilP (Figure 4A , left), is recognized to be a member of the heavy-
metal resistance efflux P-type ATPase family ATPase that probably pumps Ag(I) from the cell 
cytoplasm to the periplasmic space (Figure 4B).
125
 SilP includes all the specific features of a P-type 
ATPase,
126
 but there is one salient difference between SilP and other heavy-metal efflux ATPases, 
which is that ATPases have one to six copies of a Gly-Met-X-Cys-X-X-Cys sequence towards the N 
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terminus, whereas SilP lacks cysteines in a comparable location. Instead of a cys-rich region, SilP 
has His5-Asp-His2motifs. There is no silP homolog in the region of the E. coli chromosome 
corresponding to silABCRS homologs. SilCBA consist of a three-polypeptide membrane potential-
driven cation/proton exchange complex (Figure 4)           m m           “               u        
           v     ” (RND) superfamily of cation efflux pumps.16 The components of this presumed 
Ag(I) efflux system include (a) inner membrane SilA, the large 1048-amino acid proton/cation 
antiporter, (b) the outer membrane protein SilC, which assures transport across the periplasmic space 
of Gram-negative bacteria and directly to the outside of the cell without release into the periplasmic 
space and (c)           u           ‘m m       u             ’    B                               
membrane and connect to the outer membrane protein, SilC.  
Although silver resistance and its regulation has been studied in molecular detail in this Sil system, 
there are still discussions whether there is a real resistance towards silver or whether resistant 
microbes only eliminate the silver species.  
Here, we describe how overexpression of several different genes in E.coli can provide not only 
independently increased resistance to antimicrobial silver, but also to other metals
127
 and antibiotics. 
Our data support the notion that silver nanoparticles achieve their antimicrobial activity chiefly by 
releasing Ag ion and that killing is mediated by reactive oxygen radicals. Further, we identify 
several mechanisms by which bacteria overcome such metal-ion mediated antimicrobial action and 
describe how low-level resistance may evolve toward increased silver resistance. 
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Chapter 2    Selection of genes conferring silver resistance 
in bacteria 
Introduction 
After their discovery, antibiotics largely replaced silver and other antimicrobial compounds, which 
became nearly forgotten for almost 50 years. However, the increase in antibiotic-resistant bacteria 
has revived the interest in the antimicrobial effects of silver and its compounds. Silver, as a broad-
spectrum antimicrobial agent is increasingly used in medical and consumer products. However, 
exactly how silver exerts its the antibacterial action remains largely unclear. In addition, the question 
whether pathogenic bacterial strains may eventually evolve resistance against silver is a little-
explored question of great practical relevance. Moreover, it is also of concern that silver may 
provide an indirect selective pressure for antibiotic resistance in bacteria,
1,2
 further underlying the 
importance of understanding resistance mechanisms in bacteria, not only to antibiotics, but also to 
other antimicrobial compounds such as silver.  
A declining pipeline of clinically useful antibiotics has made it imperative to develop more effective 
antimicrobial therapies, particularly against difficult-to-treat Gram-negative pathogens. Numerous 
studies have attempted to resolve this question.
3,4
 As a result, increasingly more pressure has been 
put on developing new antibiotics or searching some new approaches for overcoming the bacterial 
resistance, like altering the structure of antibiotics or using dual action antibiotics. For example if 
bacteria have resistance to one of antimicrobial agents, another  may be used to counteract resistance 
               m   m     y   y   u         vu                    u                        β-
lactama         u                    β-lactam antibiotics.5 Therefore, research into resistance 
mechanisms and novel antimicrobials are complementary.  
Amongst all inorganic antimicrobial agents, silver elements and compounds of nanoparticles have 
been the most extensively tested ones as antimicrobials. It is possible that the inherent antimicrobial 
activity of silver in combination with conventional antibiotics can improve their efficacy.
6 
In 
summary, the exploration of the mechanism of silver antimicrobial action and mechanisms of 
resistance are relevant in light of recent efforts in combining the potential therapeutic effects of 
antibiotics and inorganic nanosilver or silver ion, in the search toward new and improved 
antibiotics.
3  
To research bacterial resistance to silver and to find methods to improve the antimicrobial activity of 
silver, it is useful to assess the susceptibility of a bacterial strain to the antimicrobial agent, as 
defined by the Minimum Inhibitory Concentrations (MIC). The MIC is defined as the lowest 
concentration of an antimicrobial that will completely inhibit the visible growth of a microorganism 
after certain incubation time. The measure of MIC is important to confirm resistance of 
microorganisms to an antimicrobial agent and also to monitor the activity of new antimicrobial 
agents.
7
 For example, one can determine that a given plasmid gives more resistance to silver by 
comparing MIC value to that of a control strain. The higher the MIC value is, the more resistance the 
clone is to the antibacterial agent tested.  
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To identify genes conferring resistance to antimicrobial silver, either in the form of silver nitrate or 
citrate-stabilised silver nanoparticles, we exploited E.coli as a model system, selecting plasmids 
from the ASKA library that raised the minimal inhibitory concentration for these inorganic 
antimicrobial compounds. The ASKA library contains more than 4000 Escherichia coli K-12 Open 
Reading Frames, representing the majority of this model bacterial genome.
8
 Following selection and 
validation of several silver-resistance genes, the effects of induced overexpression with IPTG 
(isopropyl-β-d-thiogalactoside); the effects of oxygen; as well as cross-resistance with different 
silver compounds and other antimicrobial compounds, including antibiotics were explored in further 
detail. Here, plasmids-encoded genes conferring increased resistance to silver were obtained and 
validated against the control strain (strain carrying plasmid without any insert). To research the 
effect of cross-resistance, different types of silver preparations and other metal ions were tested. In 
particular, we compared the toxicity of silver nitrate to metalic silver(0) stabilized in citric acid or 
gelatine (a generous gift by Nanotrade, Czech Republic) and by conducting antibacterial assays 
under both aerobic and anaerobic conditions.
 
Whereas zero-valent silver metal is largely insoluble in 
water,
9
 Ag
+
 can be released from AgNPs following oxidation of Ag(0) on the nanoparticle surface.
10
 
The resistance of anti-silver genes to antibiotics and synergistic of antibiotics in combination with 
silver were also tested. Finally, the production of reactive oxygen species (ROS) induced by silver 
ion was also examined.  
2.1 Material and Methods 
Materials 
Escherichia coli XL1-Blue was purchased from Stratagene. Luria Broth (LB) medium was used as a 
     m   um.       y                m              u                               5     34 μ /m   
when added to either liquid or solid medium. Liquid cultures were aerated by shaking on a rotary 
shaker (200 rpm), and all growth incubations were at 37°C. Agar (used at 1.5%) and agarose (used at 
1%) were purchased from Invitrogen. Electro competent cells and chemical competent cells of E. 
coli were prepared by standard protocols. IPTG was used at a final concentration of 1 mM. All other 
chemicals were purchased from Applichem, unless otherwise specified. The ASKA (A complete Set 
of Escherichia coli K-12 Open Reading Frame Achive) library comprises every E. coli open reading 
frame cloned into the expression vector pCA24N.
8
 10 and 50 nm AgNPs were purchased from 
Nanocomposix and stabilised with 2 mM citrate acid. These particles had a reported mean size of 
10±1.8nm and 50±5.2nm. The AgNPs solution was diluted in Milli-Q water. Metallic silver(0) and 
ion silver colloid were provided by Nanotrade.cz. The Live/Dead dyes (SYTO 9 green-fluorescent 
nucleic acid stain and the red-  u          u                         um        (PI))     3ʹ-(p-
hydroxyphenyl) fluorescein (HPF) dyes were purchased from Life Technologies (Figure 1).  
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Figure 1. (A) Transmission electron microscopy images of 10 and 50 nm AgNPs. (B) Nonfluorescent 
hydroxyphenyl fluorescein (HPF) and propidium iodide (PI). 
Experimental methods  
2.1.1 Transmission Electron Microscopy (TEM) 
The size and the morphology of the silver nanoparticles purchased from Nanocomposix were 
examined by transmission electron microscopy (TEM) using a Philips EM420 instrument at 120 kV, 
at the Biozentrum Microscopy Facility. TEM samples were prepared by dripping a drop of AgNPs 
solution on copper grids and placing the grids at room temperature to make solution evaporate 
(Figure 1). 
2.1.2 Testing the effect of size and concentration of AgNPs and reaction time on 
antibacterial activity— E. coli XL1-Blue  
Scheme 1. Schematic representation of experimental process of MIC 
 
E. coli XL1-Blue cell was cultured in 5 ml of LB containing appropriate amounts tetracycline and 
  u      v            37°                  u     .       x    y  100 μ         u  u   XL1-Blue was 
inoculated into 10 ml of LB medium with tetracycline and then the culture was incubated at 37°C in 
a shaking incubator until the OD600 was around 0.4. 1 ml of sample was taken to centrifuge and the 
 u                       .  u                         u           200 μ     A NP        v           
(Figure 2 shows the concentration of AgNPs and silver nitrate used for the MIC) and incubated for 1 
     37°                     10 μ      u  u                    u       100   m  .       y 100 μ     
dilution was spread to agar plate and the dishes were incubated upside down for 24 h at 37°C. MIC 
was assessed by checking CFU. When no growth of bacteria was observed in the medium containing 
 21 
the lowest concentration of test materials, the MIC of the test material was defined at this point of 
dilution. 
2.1.3 Selection of anti-silver genes in the absence and presence of IPTG  
First, the pooled plasmids of the ASK library were transformed into E. coli XL1-Blue bacterium by 
electroporation (1.8 Kv, 0.1 cm cuvettes), then recovered with 1 ml of SOC medium containing 
tetracycline for 1 hour at 37°C in a shaking incubator (Scheme 2A). When getting the transformed 
bacterium, we collected all these colonies with LB medium and used the pool to inoculate 10 ml of 
LB medium with tetracycline and chloramphenicol in the absence or presence of 1 mM IPTG. The 
culture was incubated at 37°C in a shaking incubator until the OD600 was around 0.4, then 1 ml of 
sample was taken to centrifuge and the supernatant was discarded. Further, the pellet was 
   u           200 μ     100     200 µ /m     A NP  (       from the MIC testing) or silver 
           u            u          1      37°                       m  1.       y  10 μ      u  u   
                 u       100   m  . 100 μ        u                                    u          24   
at 37°C (Scheme 2B). After getting surviving colonies, the second round of selection can be 
conducted by collecting the survival colonies from the first round of selection. Some single colonies 
were picked from the surviving colonies of pre-selection or non-selected and their DNA plasmids 
purified (by miniprep using a Machery Nagel kit) for DNA sequencing (Starseq AG, Germany or 
Microsynth, Switzerland). 
Scheme 2. Schematic representation of process of anti-silver plasmid genes selection  
 
2.1.4 Validation of anti-silver genes selected in the absence and presence of IPTG  
The genes selected in the absence or presence of IPTG were individually retransformed by standard 
chemical method into E. coli XL1-Blue. Then a single colony of each transformed bacteria was 
picked and cultured in 5 ml of LB containing appropriate amounts of chloramphenicol and 
tetracycline over night at 37°C in a shaking incubator. The next day precultures were inoculated into 
LB medium with tetracycline and chloramphenicol in the absence or presence of 1 mM IPTG and 
incubated at 37°C in a shaking incubator until the OD600 was around 0.4 (incubated about 3 h with 
IPTG). A defined volume of culture was mixed with different types of silver and incubated for 
defined times at 25°C. Meanwhile 10 µl of sample was taken at different incubation times and 
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diluted 100 times with sterile MQ H2O from which aliquots were spread on plates. The test materials 
AgNPs or metallic silver(0) preparations as well as silver ion supplied as silver nitrate were diluted 
when necessary with sterile MQ H2O.  
For the Live/Dead assay, after the strains induced by IPTG (OD600 0.4) were incubated with silver 
ion or AgNPs for 3.5 h at 25°C, 1 ml of culture was taken to centrifuge and resuspended in 8.5% 
sodium chloride containing 0.3% Live/Dead mixed dyes (1:1): 300 µl for bacteria incubated with 
silver ion and 15 µl for AgNPs. The bacteria were then stained at 25°C for 10 min. After that, 
bacteria were centrifuged and resuspended in 300 µl or 15 µl of 8.5% sodium chloride solution. The 
images were acquired using a fluorescence microscope (AX10, Zeiss, Unispital Basel), and merged 
using Image J program. Live/Dead dyes provide a novel two-color fluorescence assay of bacterial 
viability: SYTO 9 green-fluorescent nucleic acid stain and the red-fluorescent nucleic acid stain, 
       um        (PI). A              u      ’       u             u                Y O 9       
generally labels all bacteria in a population — those with intact membranes and those with damaged 
membranes. In contrast, propidium iodide penetrates only bacteria with damaged membranes, 
causing a reduction in the SYTO 9 stain fluorescence when both dyes are present. The 
excitation/emission maxima for these dyes are about 480/500 nm for SYTO 9 stain and 490/635 nm 
for propidium iodide. 
 2.1.5 Testing cysD overexpression in presence of Cd2+, Al3+, Pb2+ and Cu+. 
The selected gene cysD which gives the most resistance to silver also was tested with other different 
metal ions. This gene and the empty pCA24N vector were individually retransformed by chemical 
method into E. coli XL1-Blue. The experimental process is the same as for section 2.1.4 The ASKA 
strains culture with the resistant gene and empty control were incubated in the presence of IPTG at 
37°C until the OD600 was around 0.4, then different concentrations and valences of metal ions (CdCl2, 
AlCl3, Pb(NO3)2, CuBr) were added and the cultures were incubated for 7 h at 25°C. 10 µl of sample 
was taken at different incubation times and diluted 100 times with sterile MQ H2O from which 
aliquots were spread on plates.  
2.1.6 Protein analysis and measurement of thiol groups in bacterial extracts. 
ASKA strains were grown in LB medium containing tetracycline and chloramphenicol at 37°C 
under induction of IPTG or not. When OD600 reached 0.4, 1 ml of sample was taken as the control. 
Then silver solution was added to final concentration of 6 µg/ml for silver ion supplied as silver 
nitrate and the culture was incubated for 7 h at 25°C. One ml of sample was taken at 3.5 and 7 h for 
the analysis of proteins expressed with and without IPTG. To extract the protein, the pellet from the 
1 ml of culture was lysed using lysis buffer containing 1 mM PMSF as well as DNAse l and was 
shaking at room temperature for 1 h. The lysate was centrifuged and the soluble part was analyzed 
by SDS-PAGE in order to measure the expression of proteins in the IPTG induction or not. To make 
polyacrylamide gels, the stock solution used was: 30% acrylamide, 1.5 M Tris-HCl buffer (pH 8.8), 
20% sodium dodecylsulfate, 0.5 M Tris-HCl buffer (pH 6.8), 15% ammonium persulfate (APS) 
solution, and tetramethylethylenediamine (TEMED). In running gel polyacrylamide is 12%, and 5% 
in stacking gel. SDS-PAGE analyses were carried out according to Laemmli, and protein estimations 
followed standard protocols.
11
 
 23 
Thiol groups were quantified by Ellman's assay: 2.5 ml of a reaction buffer containing 100 mM 
sodium phosphate (pH 8) and 1 mM EDTA was prepared, then 50 µl of a 5,5'-dithiobis-(2-
nitrobenzoic acid) solution and 250 µl of protein lysis solution from the culture induced by IPTG 
(obtained according to the above method) was added into the above reaction buffer containing 
EDTA. The absorbance at 412 nm was measured after the mixture was incubated at room 
temperature for 30 min. A molar extinction coefficient of 14150 M
-1
cm
-1
 can be used to calculate the 
thiol concentration.  
2.1.7 Comparison of silver resistance of selected genes under anaerobic and aerobic 
conditions or presence of H2O2 
To explore the role of oxidative stress on antimicrobial activity of silver, we tested the anti-silver 
ability of the selected genes to silver under anaerobic and aerobic conditions, as well as in presence 
of H2O2. Cultures with 0.4 OD600 were induced with IPTG for 3 h, and one half degassed with 
nitrogen for about 30 min; then the metallic silver(0) and silver ion were added to the cultures by 
injection. Meanwhile H2O2 was added to another set of culture with oxygen. The cultures with and 
without oxygen were incubated at 25°C for defined times. Samples (10 µl) were taken at different 
incubation times and diluted 100 times with sterile MQ H2O, from which aliquots were spread on 
plates.  
2.1.8 Measurement of OH• produced by Ag+ induction 
 y   xy           (•O )   v        u                  u       m                   .      P  (3ʹ-
(p-hydroxyphenyl) fluorescein) assay was used to measure intracellular accumulation of hydroxyl 
radicals. Non-fluorescent HPF can be oxidized by hydroxyl radicals to a fluorescent derivative. The 
cultures were incubated for 3 h after adding IPTG until OD600 is ~0.4. Then 1 ml of culture was 
added to the corresponding concentration of silver ion and HPF (final concentration 5 µM; 0.1% 
dimethylformamide as a cosolvent). Samples were incubated at 25°C for 1 h and then centrifuged to 
remove excess. The bacterial pellet was resuspended with 1×PBS buffer, PH 7.4. The samples were 
analysed with a fluorescence microscope (AX10, Zeiss) or Tecan Flurimeter. The fluorescence 
intensity was measured at 515 nm with excitation at 490 nm. 
2.1.9 The synergistic effect of antibiotics and silver on anti-silver genes  
To test effects of antibiotics on selected strains, a similar experimental process was used as with 
silver resistance tested on agar plates (see section 2.1.4). To determine any synergistic effects, 
different concentration of antibiotics (ampicillin and kanamycin) and silver as well as the 
combination of both were added to the 0.4 OD600 of culture induced by IPTG and incubated for 7 h 
at 25°C. Samples (10 µl) were taken at 3.5 and 7 h and diluted 10 times with sterile MQ H2O, from 
      4 μ        u                              .  
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2.2 Results 
2.2.1 The effect of size and concentration of silver and reaction time on 
antibacterial activity—E. coli 
In order to research the effect of concentration of silver and size of AgNPs on bacteria, we used E. 
coli XL1-Blue bacteria (without any transformed plasmid) to test the MIC. The experimental process 
is shown in Scheme 1. In general, bacteria incubated in the presence of added silver ion had less 
survival than those subjected to 10 and 50 nm AgNPs, at the same concentration of silver content 
(Figure 2). Even at the concentration of silver ion as low as 5 µg/ml, only about 40% survived after 
20 minutes incubation. In contrast, bacteria in the presence of AgNPs have high survival, even at 50 
µg/ml, that is 10 times higher than the MIC of silver ion, underscoring that the antibiotic ability of 
AgNPs is relatively weak compared to silver ion. However, antimicrobial activity of AgNPs was 
dose-dependent from 20 µg/ml, where survival of bacteria is almost the same as control, to 400 
µg/ml, at around the MIC Activity was also time-dependent: in all cases, when bacteria were treated 
with silver for 60 min, less bacteria survived at the same concentration compared to 20 min 
treatment. Finally, the antimicrobial activity of nanoparticles was also size-dependent: bacteria 
incubated with 10 nm AgNPs had less survival than 50 nm AgNPs. For example, 10 nm AgNPs had 
20 times less survival than 50 nm AgNPs at the concentration of 100 µg/ml. The results 
demonstrated silver ion has much more antibiotic activity than AgNPs. In our experimental 
conditions, the MIC of silver ion and 10 nm AgNPs is 20 µg/ml and 400 µg/ml respectively. For the 
selection of resistant genes, we chose conditions close to the MIC based on these preliminary 
            m  y    u           1         100     200 μ /m  A NP      5 μ /m     v      .  
 
Figure 2. The effect of concentration of AgNPs and silver nitrate on the antimicrobial activity. Bar graphs 
compared to the antimicribiol activity of 50 nm, 10 nm and silver ion under a series of concentrations from 0 
to 400 µg/ml. the bacteria was incubated 20 mins (A) and 60 mins (B) after adding silver ion and AgNPs.  
2.2.2 Selection of anti-silver genes in the absence and presence of IPTG  
Selection of anti-silver genes in the absence of IPTG 
We initially selected anti-silver genes in the absence of IPTG, using a stringent selection in low-level 
constitutive expression of cloned proteins. In a first round of selection many clones survived using 
50 nm AgNPs (40 colonies). In contrast, less and no ASKA strains survived in presence of 10 nm 
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AgNPs (14 colonies) and silver ion (no colonies) under 100 µg/ml of condition, which reinforced the 
notion that large nanoparticle size of AgNPs leads to lower toxicity than small size. Similar results 
were found in subsequent experimental replicates. A second round of selection was conducted using 
all strains surviving from the first round of selection, l          m              u v v            “   -
              ”          “                 ”     50  m A NP  (      1).        u           -selection 
can give increased numbers of survivors supports the view that silver-resistance is genetically-
encoded by the plasmids. Since the selected ASKA strains gave more resistance to AgNPs, we 
picked and sequenced the inserts of some of the selectants (Table 1). In the pre-selection with10 nm 
AgNP both sequenced genes were identified as iscA, encoding a sulfur-iron protein (see Chapter 4). 
The other 3 sequenced ASKA plasmids selected at a replicate experiment were yphH, gpH and ycdB. 
Surprisingly, all seven sequenced colonies from a second round of selection were found to harbour 
ydgT, which indicates that ydgT may confer higher resistance to silver than other ASKA plasmid 
genes in the absence of IPTG.  
Table 1. The selection conditions and sequencing results of anti-silver genes using E. coli XL1-Blue bacteria 
containing ASKA plasmids in the absence of IPTG. 
Solution  Ag   
concentration  
ASKA-1 (CFU) 
(preselected with 
10 nm AgNP) 
ASKA-2 (CFU) 
(no preselection) 
10 nm AgNPs 100 µg/ml  No survivors  No survivors 
200 µg/ml  No survivors No survivors  
50 nm AgNPs 100 µg/ml  25 (pick 6)  3(pick 3)  
200 µg/ml  1   (pick 1)  No survivors 
Silver ion 100 µg/ml  No survivors  No survivors  
200 µg/ml  No survivors No survivors 
 
Sequences  Gene  
ASKA-1,  2st round of selection  ydgT a (7 copies) 
ASKA-2, no preselection, 50 nm, 100 µg/ml ycdBb, yphH b, gpH b 
ASKA-1,  1st round of preselection (pre-selection) iscAc (2 copies) 
a: Two rounds of selection 
b: Replicate of 1st round of selection 
c: In the pre-selection with 10 nm AgNP (1st round of preselection) 2 clones sequence were  identified as iscA, which is researched 
further in chapter 4. 
Selection of anti-silver genes in the presence of IPTG 
Table 2. The selection conditions and sequencing results of anti-silver genes using E. coli XL1-Blue bacteria 
containing ASKA plasmids in the presence of IPTG. 
 
 
 
 
Sequences  Gene  
yeaO (4 from AgNPs, 2 from AgNO3)  
cysD (5 from AgNPs, 14 from AgNO3)  
yabQ (2 from AgNO3) 
Other 13 plasmids: thiQ, insA, yihD, cheY, ygeK, gcyT, ygiG, 
aroB, flhD, yceQ, yjdI, yraN, hofM 
Ag concentration CFU 
100 µg/ml AgNPs (10 nm) ~250  
200 µg/ml AgNPs (10 nm) ~200  (picked 20 colonies) 
5 µg/ml Ag ion 20  (picked 20 colonies) 
10 µg/ml Ag  ion no 
20 µg/ml Ag  ion no 
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Due to ASKA plasmid genes can be overexpressed under IPTG induction and overexpression of 
proteins may be able to impart more resistance to silver, we further selected the anti-silver genes 
from the ASKA library using IPTG with 1mM as inducer, using stringent selection conditions: Ag 
ion and 10 nm of AgNPs, which had higher antibacterial activity than 50 nm AgNPs. More strains 
survived under induction of IPTG compared to the condition without induction of IPTG at the same 
concentrations of AgNPs (Table 2), suggesting that protein overexpression leads to more resistance. 
For silver ion, strains only survived at 5 µg/ml, which confirmed that the toxicity of silver ion is 
much higher than for AgNPs. New candidates for silver resistance genes with IPTG induction were 
identified, such as genes cysD, yeaO and yabQ. Interestingly, 19 out of 40 colonies sequenced 
harboured cysD, 5 of which were from selection with AgNPs and 14 were from AgNO3 selection. 
This result suggests strongly that cysD confers high-level resistance against silver and, further, that it 
exerts cross-resistance to both AgNPs and silver ion. Plasmids with yeaO were also selected from 
both AgNPs and AgNO3, which also indicates cross-resistance mechanisms of yeaO. In addition, 
two copies of yabQ were selected, both from AgNO3.  
2.2.3 Validation of selected anti-silver genes  
Validation of cross-resistance to silver ion  
In order to validate the anti-silver ability of the selected genes, a negative control strain harbouring 
an empty pCA24N vector and a positive control cueO
10 
were chosen to compare the anti-silver 
ability with the selected genes in the absence and presence of IPTG. The positive control, cueO, is a 
multicopper oxidase with a methionine-rich segment, which can bind to silver ion.
12
 The empty 
pCA24N was used for the negative in order to ensure the same growth condition for the strains. The 
anti-silver ability was determined by either plate-based or broth-based methods.  
 
Figure 3. (A) Growth curve of strain with selected plasmids and control strains (cueO and empty as positive 
and negative control, respectively) during exposure to 5 µg/ml of silver ion for 21 h at 25°C in LB medium. (B) 
count of colony forming units (cfu) of strains incubated with silver ion for 9 and 21 h in LB in the presence of 
IPTG. The results represent the averages of three replicates with standard deviations. 
To measure the anti-silver ability of these selected genes after adding silver, first the three genes 
identified in different clones, cysD, yeaO and ydgT were chosen for further validation. A broth-based 
method, in which 5 μg/ml of AgNO3 were added to ASKA strains induced by IPTG (OD600 0.4), 
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followed by monitoring OD600 at 25°C for 21 h, suggested that cysD and cueO had the most 
survivors. The plate-based assay confirmed these results, showing that when strains were incubated 
with silver ion for 9 h, the survival of strain cysD is much higher than other strains even the positive 
strain cueO. After 21 h of incubation, survival of cysD is still high but other strains almost have no 
surviving colonies.  
Validation of cross-resistance to silver ion and AgNPs 
 
Figure 4. Comparative analysis of the anti-silver ability of strains selected (A) Bar graphs of bacterial count 
for 6 µg/ml AgNO3 and (B) 200 µg/ml AgNPs in the presence or absence of IPTG after 4 and 3 h of incubation. 
(C) corresponding petri dishes of strains incubated with 6 µg/ml AgNO3 and 200 µg/ml AgNPs. The results 
represent the averages of three biological replicates with standard deviations. 
Further, we compared anti-silver ability of the selected genes by incubating the selected strains in the 
presence of Ag ion or 10 nm AgNPs as antimicrobial agents in the presence or absence of IPTG 
(Figure 4). Since yphH and gpH selected without IPTG did not show more resistance to silver than 
control (data not shown), these two genes were not studied further. The other 13 single genes 
selected with IPTG were not verified further because they were found only in single clones, 
suggesting lower resistance. In these validations, more colony forming units were also present with 
IPTG induction than without, which indicates that higher protein expression is related to resistance. 
There were many more survivors with strains cysD and ycdB than with all other strains tested, for 
both types of silver after 4 and 3 h of incubation with silver in the presence of IPTG (Figure 4A and 
B). However, yeaO, yabQ and ydgT also exerted moderate resistance to silver under induction of 
IPTG, compared to the empty control. The order of resistance ability of all strains to silver ion and 
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AgNPs was coincident, that is, strains cysD and ycdB have higher resistance to silver ion and AgNPs 
compared to other strains. The expression of cysD gave by far the higher resistance. The much 
higher toxicity of Ag ion and the anti-silver ability of the selected ASKA genes regardless of the 
form of silver are consistent with the notion that silver nanoparticles exert their antimicrobial activity 
chiefly by releasing Ag ion.  
Figure 5. Fluorescence microscopy of  strain cysD (A) and (B) empty treated with 6 µg/ml Ag ion; strain cysD 
(C) and (D) empty treated with 200 µg/ml AgNPs for 3.5 h using Live/Dead dyes. The bar graphs display the 
number ratio of live/dead bacteria from two pictures. n represents the number of live bacteria ,which serves as 
100% standard. 
Treatment with some antibiotics or with silver can lead to increased cell length
13
 and increase the 
permeability of membrane.
3(c)
 We asked whether silver can prompt bacteria to elongate and increase 
the permeability of membrane in the different selected strains. We also want to detect the viability 
and morphology of strains harbouring cysD or the empty plasmid control. Comparison of the cell 
morphology of silver ion or AgNP-treated strains cysD and empty revealed no obvious differences 
by microscopy indicating that silver did not induce large changes in the shapes of strains (Figure 5), 
such as cell-elongation, which has been observed upon treatment with silver or certain antibiotics.
13
 
However, visualization and quantification of cells stained with SYTO 9 stain (green color, indicating 
viability) and PI stain (red color, indicating membrane damage) confirmed increased viability and 
less membrane damage for the cysD strain compared to the empty control, both in presence of silver 
ion and AgNPs. These results are consistent with other forms of validation of increased cysD 
resistance to silver, such as quantification of colony-forming units.  
Cross-resistance to other types of silver 
We also explored resistance of cysD and ycdB to commercial metallic Ag(0) stabilized in gelatine 
and Ag ion colloid (kindly provided by Nanotrade), to confirm the universality of resistance of these 
two genes to different kinds of silver of commercial relevance (Figure 6). Consistent with previous 
results with AgNO3 and with citrate-stabilised AgNPs, both cysD and ycdB had increased resistance 
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compared to empty control, using 10 µg/ml of Ag ion colloid and 55 µg/ml metallic Ag (bar graph 
from Figure 6A and B). As previously found, cysD exerted the greatest resistance also for these 
alternative antimicrobial silver preparations. 
 
Figure 6. Comparative analysis of strains cysD and ycdB to metallic Ag(0) stabilized in gelatine and Ag ion 
colloid. (A) and (B) Bar graphs of bacterial count and (C) petri dishes of strains incubated with 10 µg/ml Ag 
ion colloid and 55 µg/ml metallic Ag(0) for 7 h with IPTG induction. The results represent the averages of 
three biological replicates with standard deviations. 
2.2.4 Cross-resistance of cysD to Cd2+, Al3+, Pb2+ and Cu+  
Ag(I) and Cu(I) ions are both soft metals and have the same outer electronic configuration, with a 
closed-shell structure (d10), and similar binding properties to ligands such as proteins. Copper 
detoxification systems in general, bind and transport both Ag(I) and Cu(I). For example, Ag(I) binds 
CueO at the same sites like Cu(I) substrate ions in CueO;
14
 CueR
15
 can bind and transport Cu(I) and 
Ag(I) cargos at the same sites. In isolated membrane vesicles, CopB pumped Ag
+
 and Cu
+
 at similar 
rates and with similar affinities.
16
  Other observations also suggest that copper ATPases can pump 
silver, such as CopA of Archaeoglobus fulgidus, which was shown to be more strongly activated by 
silver(I) than by copper(I).
17
 The possibility for combined Cu(I)/Ag(I) stress is common.
18
 On basis 
of the fact that Cu(I)-binding sites in proteins can often bind Ag(I), we hypothesized the possibility 
that anti-silver genes may be also exert cross-resistance to Cu(I). In addition we explored the extent 
of specificity compared with other metal ions. Cd
2+
, Al
3+
, Pb
2+
, and Cu
+
 were chosen to test 
antimicrobial ability of strain cysD (Figure 7). Under the conditions tested, both Al
3+
 and Pb
2+
 were 
only moderately toxic and no significant differences in survival were found between the cysD and 
empty strains (data no shown). However, clear differences were found both for CuBr and CdCl2 
indicating that cysD also provided some cross-resistance to Cu
+
 and Cd
2+
.  
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Figure 7. The increased ability of strain cysD to survive in presence of different metal ions. (A) and (B) Bar 
graphs of bacterial count surviving in the presence of Cu
+ 
and Cd
2+
. (C) corresponding representative petri 
dishes of strains incubated with 400 µg/ml Cu
+ 
and 550 µg/ml Cd
2+
. The results represent the averages of three 
biological replicates with standard deviations for Cu
+ 
and Cd
2+
. 
2.2.5 SDS-PAGE analysis of protein extracts.  
Analysis of cell extracts of cysD, ycdB, cueO     “empty”          y  D -PAGE/ coomasie staining 
(Figure 8) revealed the following : 
 Level of expression of CysD (35.203 KDa) was not visible for all different experimental 
conditions tested, compared to strain empty, indicating the expression of CysD protein is 
very low even under induction of IPTG. 
 For YcdB, very little protein is detected in the soluble cell extracts at approximate 48.3 KDa 
under induction of IPTG and without addition of silver ion, which corresponded to the full-
length intact polypeptide YcdB. YcdB and CueO genes both contain Tat signal sequence, so 
both proteins can be translocated to the periplasm by the Tat export pathway, after which Tat 
signal sequences are cleaved to form a mature protein (mature protein). Only YcdB with Tat 
signal sequence (pre-YcdB) could be detected, but no mature YcdB for all conditions tested, 
indicating expression of YcdB in the periplasm was very low. 
 For CueO there were two obvious bands corresponding to the size of 58.4 KDa and 55.4 
KDa for all conditions tested, upon induction with IPTG. These two bands correspond to pre 
CueO and mature CueO (mat-CueO). The presence of these two obvious bands also 
indicates CueO was overexpressed well and that the addition of silver ion had no effect on 
the expression of CueO with IPTG induction. There was no band corresponding to CueO 
protein in the absence of IPTG, which indicates that IPTG induction was effective for 
increased protein expression. 
It is particularly noteworthy that the expression of CueO and YcdB protein was apparently much 
higher than that for CysD, which was not detectable on SDS-PAGE analysis, although the silver-
resistance of cysD was much higher, thus suggesting that cysD can detoxify silver ion very 
effectively, perhaps even catalytically.   
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2.2.6 Measurement of thiol groups in cell extracts. 
CysD is an enzyme and a component of the cysteine-metabolic pathway,
19 
which indicated a possible 
silver-resistance mechanism. The amount of thiol groups in selected ASKA strains were quantified 
in cell extracts of selected strains to explore whether increased levels of this potential sulfur-donor 
ligand correlated with increased survival in presence of silver. Extracts of the ASKA strain cueO 
contained marginally more thiol groups than other ASKA strains, although this was not statistically 
very significant, while CysD had the least thiol amount. However, these minor differences were not 
significantly different, indicating that thiol amounts were probably not the main reason for the 
generation of anti-silver ability of cysD.  
 
Figure 8. (A) SDS–PAGE analysis with Coomassie blue staining of whole cell proteins from different ASKA 
strains at different incubation with 6 µg/ml silver ion with and without IPTG. Molecular mass markers are 
indicated in the middle and the left of gel. (B) The amount of thiol group of each strain overexpressed with 
IPTG. Error bars represent means SD (standard deviation) from three biological replicates. P <0.1939, P 
<0.4374  P <0.3668  P <0.4156    u    ’      . P   (           )     (m  u          ). 
2.2.7 Comparing the anti-silver ability of selected strains under anaerobic and 
aerobic conditions 
Nanosilver particles have been reported to generate the biological activity by silver ion release,
20-22
 
but there remains some controversy about the importance of these particle-based mechanisms.
9,23
 In 
order to research the mechanism of AgNPs toxicity and to explore the effect of oxygen on 
antibacterial activity of AgNPs and silver ion, we compared the anti-silver ability of ASKA strains 
cysD and ycdB to AgNPs under anaerobic and aerobic conditions (Figure 9A). It has been suggested 
that AgNPs can release silver slowly in the presence of dissolved oxygen and protons in the 
surrounding fluid phase, by oxidation of Ag(0)    A (І) from the surface of AgNPs.20 We postulated 
that if the biological activity of AgNPs is achieved by particle-based mechanisms, strains expressing 
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CysD could have similar survival rates under anaerobic and aerobic conditions. The number of 
surviving clones for cysD when incubated with AgNP under anaerobic conditions was about 4 times 
higher than when tested under aerobic conditions. Bacterial killing by Ag
+
 was found to be oxygen-
dependent with incubation time, with different colony forming units (cfu) found in aerobic and 
anaerobic conditions under the conditions tested. Increased resistance of cysD against silver ion 
under anaerobic conditions is likely to arise from reduced oxidative stress involved in the antibiotic 
mechanism of silver. 
   
 
Figure 9. The resistance ability of strain cysD to metallic silver and silver ions under anaerobic and aerobic 
conditions. (A) Bar graphs of bacterial count surviving in the presence of 50 µg/ml metallic silver after 6 h of 
incubation (B) and 6 µg/ml Ag
+
. Error bars represent means SD (standard deviation) from three biological 
replicates.  
The increased resistance of cysD against AgNPs (and other strains tested, see chapter 3) in anaerobic 
conditions compared to anaerobic conditions is compatible with the notion that oxidation and release 
of ionic silver (Ag
+
) is a major mechanism of antimicrobial killing (Figure 9A). These results 
suggest that under depleted oxygen AgNPs cannot be further oxidized and silver ion is not produced, 
leading to low toxicity of the particles. However, it is noteworthy that AgNPs were toxic to bacteria 
even in anaerobic conditions. Multiple silver species may coexist in AgNPs solution, including 
particulate zero-valent silver (Ag(s)), surface oxidized silver (Ag(I)-(adsorbed), reaction 1a), and 
dissolved silver cations (Ag(I)-(aq), reaction 1b);
22 
we did not exclude the possibility that the toxicity 
exerted by the AgNPs in anaerobic conditions originates in forms of silver ion that potentially 
existed in the AgNPs stock solution. 
The increased susceptibility of cysD to silver ion under aerobic compared to anaerobic conditions 
suggested that oxidative stress is involved in the antibiotic mechanism of silver ion. In order to 
confirm that effect of exogenous oxidative stress on the resistance of strain expressing CysD, we 
compared their resistance to H2O2, which can product reactive oxygen species. The results 
demonstrated that antimicrobial activity of H2O2 is concentration-dependent (Figure 10A). However, 
cysD had similar resistance to H2O2 as the empty control, suggesting that cysD does not exert a 
protective activity against exogenous oxidative stress caused by H2O2 (Figure 10B). Therefore, it 
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appears that cysD does not have a general protective mechanism against reactive oxygen radicals 
(ROS). 
 
Figure 10. The resistance ability of strain cysD to H2O2. (A) Bar graphs of bacterial count surviving in the 
presence of different concentration of H2O2 after 4 h of incubation (B) Bar graphs of bacterial count surviving 
in the presence of 2.5 µM of H2O2 after 4 and 7 h of incubation. Error bars represent means SD (standard 
deviation) from three biological replicates.  
2.2.8 The measurement of OH• produced by Ag+ induction 
It has been shown that silver may act as a catalyst for the production of hydroxyl radicals in the 
Fenton reaction.
24
 Accumulation of ROS may lead to death of bacteria.
24 
In order to research the 
resistance mechanism of bacteria to silver we determined the production and accumulation of 
intracellular hydroxyl radicals by using the fluorescent dye HPF (3ʹ-(p-hydroxyphenyl) fluorescein) 
under the condition of addition of silver (Figure 11). By fluorescence microscopy, the empty control 
strain presented more fluorescent bacteria with  increasing concentrations of silver ion from 2 to 6 
µ /m                        •O      u      (   u   11A)         u               v              u   
        u         •O             . W                        v                    10 µ /m      
fluorescence did not further increase with concentration of silver ion compared to 6 µg/ml silver ion, 
but actually decreased a little, which we ascribe to excessive killing of bacteria under these 
                              um                    u     •O .  P    u                  m  y 
control strain and CysD-expressing strain was quantified in cell suspensions by spectrometry, which 
revealed similar silver-dependent trends. These measurements revealed that cysD consistently had 
lower fluorescence than the control strain, even at basal level, i.e. without addition of silver nitrate. 
A similar behaviour was found for the ycdB strain, which like cysD also had lower fluorescence 
compared to the empty control strain, even in the absence of Ag
+
. All these results suggest that silver 
ion can disrupt metabolic pathways, leading to increased Fenton chemistry and overproduction of 
hydroxyl radicals, and that cysD and ycdB may be protecting against Ag
+
-mediated cell-killing 
    u      v             m         •O -radical. This scenario is consistent with the observation that 
resistance of cysD to Ag
+
 was also oxygen-dependent (Figure 9), this is, silver ion can induce the 
production of hydroxyl radicals, particularly in the presence of oxygen.  
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Figure 11. •O      u         u     y A + in the Fenton reaction. ( A) fluorescence microscopy of HPF-
stained 1 h of strain empty cells with (a) 0 µg/ml Ag
+
; (b) 2 µg/ml Ag
+
; (c) 6 µg/ml Ag
+
; (d) 10 µg/ml Ag
+
; (B) 
fluorescence histogram of strains cysD and empty cell dyed by HPF for 1 h with different concentration of Ag
+
. 
(C) fluorescence histogram of strains ycdB, cysD and empty cell dyed by HPF for 1 h with 0 µg/ml Ag
+
 and 6 
µg/ml Ag
+
. Scale bar in Figure A is 50 µM. 
2.2.9 The synergistic effect of antibiotics and silver in bacteria expressing silver-
resistance genes  
It has been suggested that AgNPs and silver ion can increase the antimicrobial activity of 
antibiotics.
3
 Therefore, we asked the question whether the anti-silver genes we identified could also 
give rise to resistance to some antibiotics. To investigate the effect of silver-resistance genes on the 
potential synergistic antimicrobial effect of silver combined with antibiotics we chose to investigate 
combinations of silver and antibiotics that were sub-lethal when used alone (Figure 12). Neither 6 
µg/ml kanamycin nor 2 µg/ml silver ion had much antimicrobial effect on the strains cysD and ycdB 
after incubation of 3.5 h and 7 h. In contrast, kanamycin had evident antimicrobial activity against 
the empty control strain after incubation of 7 h, indicating that the selected genes cysD and ycdB, 
selected for silver-resistance, also gave rise to resistance to the antibiotic kanamycin. Moreover, the 
combination of 6 µg/ml kanamycin plus 2 µg/ml silver ion had a marked antimicrobial activity, 
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including against strains cysD and ycdB, achieving increased antibacterial efficiency compared to the 
individual antibacterial effect of kanamycin and silver ion (Figure 12A). Similar synergism in 
antibiotic activity between silver and kanamycin was also observed when using AgNPs (Figure 12B): 
when 2 µg/ml kanamycin and 50 µg/ml AgNPs were used separately there was no obvious 
antibacterial activity observed, but when applied together, a marked antimicrobial activity was 
evident. Importantly, neither cysD nor ycdB, both of which protect against silver-mediated killing, 
appeared to exert any significant protective effect against the combined effect of silver ion and 
kanamycin under the conditions tested.   
In presence of ampicillin, in contrast to the synergistic effect of the combination of silver and  
kanamycin, no synergy was found with silver antibiotic activity (Figure 12C): the combination of 
silver ion at 5 µg/ml with ampicillin at 24 µg/ml did not lead to increased bacterial killing. We did 
not exclude the possibility that ampicillin, which contains both sulfur and carboxyl groups, could 
itself bind to silver ion. However, it is noteworthy that cysD, which was selected for increased 
resistance to silver, also rendered bacteria more resistance to ampicillin, as well as to the 
combination of silver nitrate and ampicillin, compared to the control strain (Figure 12C).  
 
Figure 12. The resistance ability of strains cysD and ycdB to silver and antibiotics. (A) Strains treated with 2 
µg/ml Ag
+
, 6 µg/ml kanamycin or a combination of both. (B) Strains treated with 50 µg/ml AgNPs, 2 µg/ml 
kanamycin or a combination of both. (C) Strains treated with 5 µg/ml Ag
+
, 24 µg/ml ampicillin or a 
combination of both. Amp-ampicillin, Kan-kanamycin.  
To explore whether the synergistic effects of kanamycin and silver were due to the increased 
permeability of the bacterial membranes, we used propidium iodide (PI) to detect permeation of the 
cell membrane in the presence of antibiotics and silver (Figure 13A). The combination of kanamycin 
and silver led to an increase of fluorescence of both strains tested (cysD and empty control) 
compared to either antimicrobial agent alone, suggesting increased permeability of the strain 
membrane leading to increased bacterial killing. In contrast, the level of fluorescence of strains 
treated with silver in combination with ampicillin did not increase compared to either treatment 
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alone (Figure 13B), indicating ampicillin and silver had no synergistic effects on cell permeability. 
These results are consistent with the cell-viability assays (Figure 12). 
To examine the effect of combination of silver ion a                          u         •O       
combined effect of silver ion and antibiotics was examined (Figure 13C and D). Whereas the 
combination of kanamycin and silver increased the fluoresence of the PI dye, ascribed to increased 
•O      u       y     combined treatment, simultaneous treatment with ampicillin and silver did 
not lead to increased fluorescence. These results suggest that the combination of kanamycin and 
silver had a synergistic effect for the increased production of hydroxyl radicals and that the 
production of hydroxyl radical led to increased killing through disruption of bacterial membranes. 
Expression of cysD could not protect against such combined OH-mediated killing, although it 
protected against silver-mediated killing. However, expression of cysD did not confer any significant 
protection against kanamycin treatment alone. In contrast, the mechanism of antimicrobial activity of 
ampicillin and silver were not synergistic, although cysD expression can also provide some 
protection against ampicillin action.  
 
 
Figure 13. Detection of dead bacteria using PI and hydroxyl radicals using HPF for strains cysD and empty 
incubated in the presence of silver ion, antibiotics or in the combination of both. Detection of dead bacteria in 
the strains cysD and empty when they were incubated with (A) 2 µg/ml Ag
+
, 6 µg/ml kanamycin or a 
combination of both and (B) 5 µg/ml Ag
+
, 24 µg/ml ampicilin or a combination of both after incubation of 3.5 
h. Detection of hydroxyl radicals using HPF for strains treated (C) with 2 µg/ml Ag
+
, 6 µg/ml kanamycin or a 
combination of both and (D) 5 µg/ml Ag
+
, 24 µg/ml ampicillin or a combination of both after incubation of 1 h. 
Amp-ampicillin, Kan-kanamycin.  
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Figure 14. Structures of ampicillin and kanamycin. 
 
Figure 15. Generalized reaction catalyzed by ATPS enzymes. 
2.3 Discussion 
The antibiotic mechanisms of silver have been researched for a long time and some resistance 
mechanisms have been investigated, such as efflux pump system SilABC and cusCBA which can 
transport the silver ions to the outside of the cell, as well as detoxifying system copA,
17
 silE and silF 
which can bind silver ion to reduce its toxicity to bacteria. By selection of ASKA plasmid genes 
using silver and AgNPs we obtained new anti-silver determinants, including cysD and ycdB, which 
endowed bacteria with cross-resistance to silver ion and AgNPs, due to the overexpression of 
corresponding proteins.  
Although the toxicity of silver ion and AgNPs are well known and has been extensively explored, 
there is still controversy about how silver nanoparticles achieve their antimicrobial activity. Some 
believe the meta                          x       “        -        ”   x    y21 while other think AgNPs 
achieve their antimicrobial activity by releasing silver ion.
20
 Our results show that the silver 
resistance profile of selected ASKA strains is similar for AgNPs and for Ag ion (Figures 4 and 6). 
The resistance ability of ASKA strains to metallic Ag(0) depends on aeration, i.e. metallic silver has 
stronger toxicity under aerobic than anaerobic conditions. The toxicity of AgNPs is an oxygen-
dependent process,
22
 so strains have more resistance to metallic silver under anaerobic conditions 
than under aerobic conditions. We also confirmed that the large size of AgNPs has less toxicity than 
the small AgNPs. We ascribe this behavior to small AgNPs having larger surface, which can 
therefore release more silver ion. Taken together, we support the notion that the toxicity of AgNPs is 
exerted chiefly from silver ion, which can be released slowly from the surface of AgNPs in the 
presence of oxygen.  
Expression of cysD not only gives the highest resistance ability to silver but also gives more 
resistance to Cd
2+ 
and Cu
+
 under overexpression (Figure 7) compared to control. Ag(I) and Cu(I) 
possess the same outer electronic configuration, so they are closely related, and are both deemed soft 
 38 
metals that preferentially combine with ligands such as sulfhydryl and nitrogen groups. Because of 
having the similar ligand-binding chemistries, it is not surprising that some proteins or peptides 
which can bind to Ag(I) also can bind to Cu(I), such as cus system.
25
 Cu(I)-binding sites in proteins 
can often also combine to Ag(I), such as cue system.
26
 The finding that cysD, selected for silver 
resistance, can also give resistance to copper supports that the antimicrobial mechanism of two kinds 
of metal ions is fundamentally the same. Cadmium is also a soft metal and Cd(II) can bind to 
sulfhydryl groups on essential proteins, interfering with important cellular functions.
27,28
  
The antimicrobial activity of silver can be classified into three general mechanisms: (1) binding to 
thiol groups or nitrogen in proteins and disrupting their function; (2) compromising cell membranes 
leading to cell lysis; (3) oxidative stress from generation of reactive oxygen species. A surprising 
finding was that silver ion toxicity also appears to be affected by exposure to air. Our results suggest 
that silver can increase Fenton chemistry (Fe
2+
 + H2O2 →   
3+
 +  O• + O –) and induce 
overproduction of hydroxyl radicals in bacteria, which may be the main reason of bacterial-killing 
by silver ion. Ag is a redox inert metal and its thiophilic nature maybe displace Fe from Fe-S clusters, 
          u      m           u         •O -radical.29 Expression of cysD appears to protect from to 
•O -radical mediated killing. However, cysD expression did not confer more resistance to H2O2. We 
hypothesise that expression of cysD may prevent silver-m        •O -radical formation, although it 
does not appear to confer general protection against oxygen radicals.  
Multidrug-resistant, Gram-negative bacteria are an important cause of nosocomial infections.
30
 With 
the appearance of antibiotic resistant bacteria approaches to overcome such bacterial resistance must 
be sought. We explored the possible synergistic effects of antibiotics and silver against E. coli 
bacteria, in order to search for a more effective bactericidal method. Our experiments suggest that 
combination of kanamycin with silver results in a greater bactericidal effect than either of the two 
antibacterial reagents applied alone and that cysD expression, although protective against silver 
alone, is not protective to the combined effect of silver and kanamycin. These experiments provide 
solid evidence of the synergistic antibacterial effects of an antibiotic and silver, suggesting that a 
combination of suitable antibiotics with silver may potentiate the antimicrobial activity even against 
resistant strains. In marked contrast to the case of kanamycin, the combination of ampicillin and 
silver ion did not provide any improvement in the antibacterial activity, even for the control strain. It 
is possible that the lack of synergy between silver and ampicillin relates to ampicillin binding to 
silver ion: ampicilin is a beta-lactam antibiotic containing many active groups such as sulfur and 
carboxyl groups which could coordinate to silver ion, while kanamycin is an aminoglycoside 
bacteriocidal antibiotic (Fig 14). Such possible chelation of silver could eliminate the antibacterial 
activity of silver, so that only ampicillin functions as antibacterial reagent, thus leading to no 
increasing antibacterial activity (5 µg/ml Ag
+
 and 24 µg/ml ampicillin used and the stoichiometry of 
metal:antibiotic is 0.717). Alternatively, it may be that ampicillin and silver mediate similar 
microbicidal pathways in bacteria, thus leading to a common protective mechanism by cysD. 
Some researches have demonstrated that bactericidal antibiotics with a variety of different 
mechanisms of action augment ROS production within cells via the Fenton reaction.
31
 So tolerance 
to antibiotics may rest with the ability of the cell to defend itself against ROS.
28–30
 For example, the 
hydroxyl-radical scavenger thiourea protects the persister subpopulation,
32
 the coordinated stringent 
response to nutrient limitation in P. aeruginosa and E. coli was shown to increase antioxidant 
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enzyme expression and decrease production of prooxidant molecules.
33
 Intriguingly, we discovered 
that the anti-silver gene cysD also confers some resistance to the antibiotic ampicillin and kanamycin, 
pointing to the possible co-evolution of resistance to silver and antibiotics in bacteria. This raises the 
intriguing possibility that silver-resistance genes, and by extension metal-resistance genes, may 
contribute to multi-drug resistance in bacteria.
34
 
CysD is the subunit of ATP sulfurylase and responsible for directly forming APS under control of 
the G protein (Figure 15).
35
 ATP sulfurylase is an enzyme involved in activation and subsequent 
reduction of sulfate to sulfide. In order to understand the reason why cysD can give more resistance 
to silver, we first tested the overexpression amount of protein encoded by cysD and content of thiol 
group. The amount of expressed recombinant protein as measured by SDS-PAGE is very low. The 
low expression of CysD protein suggests that direct binding of the protein to silver is probably not 
its main mechanism of protection. Since CysD is involved in the cysteine anabolic pathway, we 
hypothesized that increased thiol-containing compounds such as glutathione could be protecting 
against silver toxicity. Surprisingly, the measured amount of reduced thiol groups in cell extracts of 
the CysD-expressing strain was similar (if anything lower) than in other strains. However, since the 
amount of •O -radical formation was also lower in the CysD-expressing strain, it may be that cysD 
does increase the production of thiol-containing compounds, but these are involved in increased 
qu           •O -radicals, thus rendering them oxidized and undetectable in our assays. YcdB is 
reported as a member of the dye-decolorizing peroxidase (DyP) protein family with modest guaiacol 
peroxidase activity.
36
 YcdB is a dimeric protein and contains a heme cofactor. The gene encoding 
YcdB protein encodes for a Tat signal. The Tat signal sequence of YcdB makes protein be 
translocated to the periplasm via the Tat system. In contrast to all other periplasmic hemoproteins, 
heme of YcdB is assembled into the protein in the cytoplasm, i.e. heme assembly take place before 
translocation.
36
 YcdB might be a peroxidase, which are a large family of enzymes that typically 
catalyze a reaction of the form: ROOR' + electron donor (2 e
-
) + 2H
+
 → RO  + R'O .37 So the 
function of YcdB in the periplasm may involve a detoxification reaction under specific conditions.
25
 
Therefore we speculate the detoxification of silver ion of ycdB may arise from the peroxidase 
activity, which maybe directly or indirectly reduces the toxic Ag(I) to the less toxic Ag(0) and/or be 
involved in detoxifying reactive oxygen radicals through its redox activity. In addition, the known 
silver-resistance protein CueO, used here as a positive control, is also known to be translocated to 
the periplasm by the Tat system. These and other Tat-containing proteins are explored further in 
chapter 3. 
Other identified proteins conferred low resistance to silver. The YabQ protein has not been explored 
much in E. coli; however, the homologue in B. subtilis is localized in the membrane of the forespore 
and is predicted to have five transmembrane domains and a signal sequence at the N-terminus region. 
YabQ may be a transporter for components required for synthesis of the spore cortex.
38 
The YdgT 
protein, also known as cnu, is a largely unexplored protein of E. coli and a paralogue of Hha, 
involved in binding and regulating the activity of nucleoid-associated proteins.
39
 YeaO is a 
hypothetical protein and there is practically no further information available in the literature or 
public databases. IscA, an 11 kDa member of the hesB family of proteins, binds iron and [2Fe-2S] 
clusters, and participates in the biosynthesis of iron-sulfur proteins.
40
 The laboratory evolution of 
these two latter proteins is explored in chapter 4.  
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2.4 Conclusion 
The main aim of this chapter was first to select silver resistance genes from the ASKA plasmid gene 
library using AgNPs and Ag ion in the absence or presence of IPTG and then to study possible 
m       m                         “    -   v  ”      . W               v                 
recombinant expression in E. coli gave increased resistance to silver ions and particles, including 
cysD and ycdB. Of these, cysD gave most resistance to silver and also gave resistance to copper and 
cadmium. Increased antimicrobial activity of silver in aerobic condition and fluorescence assays 
suggest that silver ion can induce the production of hydroxyl radical. Anti-silver genes cysD also 
endowed some resistance to ampicillin and kanamycin, suggesting that evolution of heavy-metal 
resistance may contribute to multiple resistance to antibiotics. However, we detected a marked 
synergy of antibacterial action between silver and kanamycin, even for the cysD strain, which had 
been selected for increased silver resistance. Our research using laboratory selection in a model 
bacterial system provides more detailed insights into mechanisms of antimicrobial silver and to the 
evolution multidrug resistance bacteria. 
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Chapter 3    The silver-resistance activity of recombinant 
Tat-signal-containing genes 
Introduction 
In the previous chapter genes were identified whose overexpression in E. coli conferred increased 
resistance to silver. One of the genes identified codes for the enzyme YcdB, a member of the dye-
decolorizing peroxidase (DyP) protein family. YcdB can catalyze the release of iron from heme and 
sequence analysis of YcdB revealed a twin-arginine motif within a leader sequence.
1
 Proteins that 
are expressed with a twin-arginine motif can be exported into the periplasm after folding, by the 
twin-arginine translocation (Tat) pathway. Another gene encoding for a Tat-sequence, CueO, was 
also chosen as a positive control in the last chapter and also shown to confer detectable resistance to 
silver. Since two proteins encoded by genes with Tat signal sequence gave some resistance to silver, 
we hypothesized that other proteins expressed by the genes with a twin-arginine motif could also 
give more resistance to silver. This hypothesis was explored in further detail and forms the basis for 
this chapter. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic of routing of the Sec and Tat pathways. Unfolded periplasmic proteins are exported via 
Sec pathway, whereas folded conformations are exported via the Tat pathway, which transport protein with 
twin arginine motifs (sufI and yedY are simply shown as examples of proteins exported through the Tat 
pathway). ref 2  
Protein translocation to the periplasm in bacteria 
Prokaryotes export proteins across the cytoplasmic membrane by two parallel and complementary 
pathways, which are the Sec and Tat pathways (Figure 1).
2
 In the Sec pathway translocation takes 
place through a threading mechanism, which demands the substrate translocated to be in an 
outstretched conformation (unfolded conformation). In contrast, the Tat (twin-arginine translocation) 
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pathway is devoted to the transport of folded proteins, i.e. only proteins that can attain a folded state 
in the cytoplasm are competent for export via Tat pathway. Proteins are targeted to the Tat pathway 
by N-terminal signal peptides. These signal peptides possess continuous, essentially fixed, arginine 
residues within an S–R–R–x–F–L–K consensus m        m   “             ” (RR)                .3 
Tat-targeted proteins are synthesised as precursors with N-terminal signal peptides. Twin-arginine 
signal peptides possess a tripartite structure consisting of a polar N-terminal region (n-region), a 
moderately hydrophobic region (h-region), and a C-terminal region (c-region) in which a protease 
cleavage site is often contained (Figure 2).
4
 The twin-arginine motif is always positioned at a 
consensus motif at the n-region–h-region boundary.4 Efficient targeting of passenger proteins in Tat 
pathways is mainly dependent on the twin arginines of the signal peptide. In Gram-negative bacteria 
and plant chloroplasts, three membrane proteins, which are termed TatA, TatB and TatC in bacteria, 
consist of Tat machineries. TatA includes a single transmembrane domain and a cytosolically 
located amphipathic helix followed by an unstructured C-terminus. The homologous TatB subunit 
that is yet functionally distinct has the same predicted structure as TatA. TatC was shown to be 
involved in recognizing twin-arginine signal peptides and mediates the transmembrane insertion of a 
twin-arginine signal sequence, thereby translocating the signal sequence cleavage site across the 
bilayer. On the other hand TatC has six predicted transmembrane helices in which the N- and C-
termini of the protein face the cytoplasm (Figure 3).
4
 The TatBC complex is related to binding RR-
signal peptides as involved by multiple experimental strategies.
5,6
 The homo-oligomeric TatA 
complex are arranged as rings to form pore-like structures, in which the protein is translocated 
acrossing through this channel formed by TatA protomers.  
 
Figure 2. The tripartite structure of Sec and Tat signal peptides. (a) The generic tripartite structure of both Sec 
and Tat signal peptides. Both types of signal peptide encompass an N-terminal positively charged region of 
variable length (n-region, shaded green), followed by a hydrophobic h-region (shaded orange) normally 
containing 15–20 amino acid residues, and a more polar C-region (shaded purple) containing the A×A (or an 
acceptable variation thereof) signal peptidase-I recognition sequence. (b) Two examples of extensively 
characterized Sec signal peptides from Escherichia coli. Other than the signal peptidase cleavage site in the c-
region, the outer membrane protein A (OmpA) and periplasmic maltose-binding-protein (MalE) signals share 
no obvious amino acid conservation. (c) Some representative twin-arginine signal peptides. The conserved 
residues that contribute to the twin-arginine motif are boxed in each case and always lie close to the n-region–
c-region boundary. The positions of highly conserved basic amino acids within the c-regions of Tat signal 
                          .          u                               ‘   - v        m     ’.7  
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Figure 3. A model for the Tat transport cycle. This model is based on complementary biochemical studies on 
the Escherichia coli and plant thylakoid systems. For clarity, arbitrary numbers of TatA protomers (green) and 
single copies of the TatB (yellow) and TatC (red) proteins are shown. Under resting (non-translocating) 
conditions, TatA and TatBC form separate high-molecular-mass complexes within the membrane. (a) A 
depiction of the E. coli inner membrane is shown with the relative positions of the periplasm and cell 
cytoplasm shown. (b) The cycle is initiated when the twin-arginine signal peptide of a Tat substrate protein 
(blue) binds the TatBC complex in the membrane. The twin-arginine motif is recognized directly by TatC.
8,9 
(c) 
In a proton-motive force (Δp)-dependent manner, the TatA complex then associates with the substrate-bound 
TatBC module. (d) The TatABC complex is now fully assembled, and the substrate protein is translocated 
across the membrane through a channel formed by multiple TatA protomers. Protein transport is probably 
driven by the transport of protons across the membrane. Following transport, the TatA and TatBC complexes 
dissociate and return to the resting state (a).
10,11 
Adapted from  publications ref 4.
 
Transport by the Tat pathway is energized solely by the membrane potential proton-motive force
12 
and the costs for translocation appear to be very high, which may be the reason why many organisms 
prefer the less energy-consuming translocation of unfolded proteins via the Sec apparatus. The most 
complete Tat substrate analyses have been reported from Escherichia coli.
4
 Many Tat substrates 
from E. coli need to be translocated in a folded conformation because they are heterodimers or 
because they are co-assembled with a cofactor in the cytoplasm. 
The Escherichia coli genome encodes at least 27 putative signal peptides containing a twin arginine 
motif characteristic of proteins exported via the twin arginine translocation pathway (Table 1).
4
 Here, 
we first tested anti-silver ability of Tat genes from E. coli and selected those having high resistance 
ability upon recombinant expression for further exploration. Five Tat-containing genes were 
identified that gave more resistance to silver than the previously-characterised ycdB and cueO genes. 
Further we functionally tested these 7 Tat-containing genes, which gave more resistance to silver 
compared to empty-plasmid controls, using recombinant constructs in which we deleted either the 
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Tat signal peptide, the His tag, the insert sequence or combinations thereof in order to research their 
effect of these sequences on anti-silver ability of bacteria. 
Table 1. A complete list of known and predicted Escherichia coli Tat substrates 
Protein Physiological role Cofactors Co-exported partner Signal chaperone 
HyaA Hydrogen oxidation 3×Fe-S clusters HyaB HyaE 
HybO Hydrogen oxidation 3×Fe-S clusters HybC HybE 
HybA Hydrogen oxidation 4×Fe-S clustersb Unknown Unknown 
NapG Nitrate reduction 4×Fe-S clustersb Unknown Unknown 
NrfC Nitrite reduction 4×Fe-S clustersb Unknown Unknown 
YagT Unknown 2×Fe-S clustersb YagRb, YagSb YagQb 
YdhX Unknown 4×Fe-S clustersb Unknown Unknown 
TorA TMAO reduction MGD None TorD 
TorZ TMAO reduction MGD None YcdYb 
NapA Nitrate reduction MGD, 1×Fe-S cluster None NapDb 
DmsA DMSO reduction MGD, 1×Fe-S cluster DmsB DmsD 
YnfE DMSO reduction MGD, 1×Fe-S clusterb YnfGb DmsDb 
YnfF DMSO reduction MGD, 1×Fe-S clusterb YnfGb DmsDb 
FdnG Formate oxidation MGD, 1×Fe-S cluster FdnH FdhDb, FdhEb 
FdoG Formate oxidation MGD, 1×Fe-S clusterb FdoHb FdhDb, FdhEb 
YedY TMAO/DMSO reduction MPT None Unknown 
CueO Copper homeostasis 4×Cu ions None Unknown 
SufI Possibly cell division None Unknown Unknown 
YahJ Unknown 1×Fe ionb Unknown Unknown 
WcaM Colanic acid biosynthesis Unknown Unknown Unknown 
MdoD Glucans biosynthesis Unknown Unknown Unknown 
YcdB Unknown Unknown Unknown Unknown 
YcdO Unknown Unknown Unknown Unknown 
YaeI Possible phosphodiesterase Unknown Unknown Unknown 
AmiA Cell wall amidase None Unknown Unknown 
AmiC Cell wall amidase None Unknown Unknown 
FhuD Ferrichrome binding None Unknown Unknown 
YcbK Unknown Unknown Unknown Unknown 
aThe E. coli K-12 genome encodes 27 polypeptides known or predicted to bear N-terminal twin-arginine signal peptides, which 
represents ～ 6% of cell-envelope proteins (currently estimated total of 452 in E. coli K-12; 
http://www.cf.ac.uk/biosi/staff/ehrmann/tools/ecce/ecce.htm). Many of these proteins bind redox cofactors, such as iron-sulphur clusters 
(Fe-S), molybdopterin guanine dinucleotide (MGD) or molybdopterin (MPT) (Figure 4). Some are co-exported with a partner protein that 
contains no signal peptide itself, and many require that activity of signal peptide-        ‘            ’                              
assembly and export processes. bPredictions inferred by homology, genetic linkage or sequence analysis; see Berks et al.5 and Turneret 
al.13 for recent reviews. 
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Figure 4. Structure of the iron-sulfur clusters and molybdopterin cofactors found in Tat-containing proteins of 
E. coli. ref 14 
3.1 Materials and methods 
Table 2. Overview of recombinant gene constructs explored. Blue titles display the part deleted from genes. 
Black bold is the name of recombinant genes.      ym    Δ                         m   .                    
indicated pairwise forward and reverse primers were used for whole-plasmid PCR. 
Deletion of TAT signal sequence (ΔT-) Deletion of His tag and TAT (ΔTΔH-) Deletion of His tag (ΔH-) Template 
name Forward 
primer 
Reverse 
primer 
name name Forward 
primer 
Reverse primer name name Forward 
primer 
ΔT-ycdB ycdB+ ASKA_delTAT- ΔTΔH-ycdB ΔT-ycdB ycdB+ ASKA_delTAT- ΔTΔH-ycdB ΔT-ycdB ycdB+ 
ΔT-cueO cueO+ ASKA_delTAT- ΔTΔH-cueO ΔT-cueO cueO+ ASKA_delTAT- ΔTΔH-cueO ΔT-cueO cueO+ 
ΔT-hybA hybA + ASKA_delTAT- ΔTΔH-hybA  ΔT-hybA hybA + ASKA_delTAT- ΔTΔH-hybA  ΔT-hybA hybA + 
ΔT-torA torA + ASKA_delTAT- ΔTΔH-torA  ΔT-torA torA + ASKA_delTAT- ΔTΔH-torA  ΔT-torA torA + 
ΔT-yedY yedY + ASKA_delTAT- ΔTΔH-yedY  ΔT-yedY yedY + ASKA_delTAT- ΔTΔH-yedY  ΔT-yedY yedY + 
ΔT-sufI sufI+ ASKA_delTAT- ΔTΔH-sufI ΔT-sufI sufI+ ASKA_delTAT- ΔTΔH-sufI ΔT-sufI sufI+ 
ΔT-ycdO ycdO+ ASKA_delTAT- ΔTΔH-ycdO ΔT-ycdO ycdO+ ASKA_delTAT- ΔTΔH-ycdO ΔT-ycdO ycdO+ 
 
Deletion of gene 
 (express only TAT and His) (ΔG-) 
 
Template 
Deletion of His and gene (express only TAT). Two step-construction. 
name Reverse 
primer 
Forward primer Name step1 delete His template step2 delete genes template 
Reverse 
primer 
Forward 
primer 
Reverse 
primer 
Forward primer 
ΔG-ycdB ycdB- ASKA_delgene+ ycdB ΔGΔH-ycdB ASKA_delHis- ASKA_delHis+ ycdB ycdB- ASKA_delgene+ ΔH-ycdB 
ΔG-cueO cueO- ASKA_delgene+ cueO ΔGΔH-cueO ASKA_delHis- ASKA_delHis+ cueO cueO- ASKA_delgene+ ΔH-cueO 
ΔG-torA torA- ASKA_delgene+ torA ΔGΔH-torA ASKA_delHis- ASKA_delHis+ torA torA- ASKA_delgene+ ΔH-torA 
 
Table 3. Primer sequences used for different candidates Tat genes in the recombinant of genes. 
Name of primer Sequence of primer Name of primer Sequence of primer 
ycdB+ 5' P CAA AAA ACG CAA AGT GCG CCG GGT AC 3' ASKA_delTAT-    5' P CGG ATC CGT ATG GTG ATG GTG ATG 3' 
cueO+ 5' P GCA GAA CGC CCA ACG TTA CC 3' ASKA_delHis- 5' P GTG AGA TCC TCT CAT AGT TAA TTT CTC CTC 3' 
hybA+ 5' P GCT GAA  AAC CGC CCG CCA ATT C 3' ASKA_delHis+ 5' P aAT ACG GAT CCG GCC CTG AG 3' 
torA + 5' P CAA GCG GCG ACT GAC GCT GTC ATC TCG AAA G 3' ycdB- 5' P TTA TGC ATG AGC GAC CGG ACA AC 3' 
yedY+ 5' P GAT CTG CTT AGC TGG TTT AAA GG 3' cueO- 5'P TTA CGC AAA TAC TGC GCG GCT C 3' 
sufI+ 5' P GCA GGA CAA CAG CAA CCG CTA CCC GTT C 3' torA- 5'P TTA CGC AGT CGC ACG TCG CGG CGT TAA C 3' 
ycdO+ 5’ 5' P  GCT GAT GTG CCG CAG GTC AAA GTG 3' ASKA_delgene+    5'P AGG AGA AGA ACT TTT CAC TGG AGT TG 3' 
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The E. coli strain used in this work was XL1-Blue. LB-medium was used as a rich medium. 
Tetracycline, chloramphenicol and IPTG were used at final concentrations of 5, 34 µg/ml and 1mM, 
respectively, when added to either liquid or solid medium. Electrocompetent cells and chemical 
competent cells of E. coli were prepared by standard protocols. Agar (used at 1.5%) and agarose 
(used at 1%) were purchased from Invitrogen. Turbo Pfu polymerase and other restriction enzymes 
are from New England Biolabs, unless specified. All other chemicals were purchased from 
Applichem, unless otherwise specified. Primers were synthesized from Microsynth, Switzerland and 
the gene sequencing was from Starseq, Germany. E. coli XL1-Blue strains were routinely grown at 
37 °C with IPTG in Luria-Bertani (LB) medium before adding silver ion supplied as silver nitrate or 
on LB plates. When adding silver ion, the cultures were incubated at 25°C. Metallic Ag(0) stabilized 
in gelatine was generously provided by Nanotrade.cz. 
3.1.1 Selection of ASKA Tat signal genes with high resistance to silver ion. 
All plasmids containing genes with Tat signal sequences listed in Table 1 were isolated from the 
ASKA library and transformed into XL1-Blue cells by standard chemical transformation. Single 
colonies from every ASKA Tat strain was tested for resistance to silver according to the experiment 
process 2.1.4. Briefly, the cultures containing preculture, chloramphenicol and tetracycline in the 
presence of IPTG were incubated to OD600 0.4 at 37 °C. Silver nitrate (6 µg/ml for silver) was added 
at OD600 0.4 and the cultures containing the ASKA plasmids were incubated for 7 h at 25°C. The 
samples were taken at 4 and 7 h followed by dropping 5 µl of different diluted culture to big petri 
plates. These plates were incubated for 24 h at 37 °C for counting of colony forming units (cfu). By 
Five genes were found to confer more resistance to silver than the empty plasmid: hybA, torA, yedY, 
sufI and ycdO.  
 
Figure 5. Sequences of the Tat signal peptides of selected proteins tested. The consensus motif is shown in red 
and the cleavage site in blue. The vertical black line indicates the site of cleavage by signal peptidase I. ref 
2,13 
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Figure 6. General strategy for deleting sequence of interest in recombinant genes (illustrated here is deletion 
of His tag of ycdB, as a representative example). 
3.1.2 Recombinant constructs of selected genes with Tat signal sequences  
To research effect of the Tat signal sequence and His tag on the anti-silver ability of genes, we chose 
to delete Tat signal peptides, both Tat signal peptides & His tag, or His tag alone for 7 selected genes: 
cueO, ycdB, hybA, torA, yedY, sufI and ycdO (Figure 5 shows the Tat signal sequences of these 7 
genes). As a control and to research the effect of these genes on their anti-silver ability, we also 
deleted the gene-insert or both the gene-insert and His-tag of ycdB (originally selected from whole 
ASKA library for silver resistance in chapter 2); cueO (positive control) and torA (which gave the 
strongest resistance to silver of the 5 Tat genes selected), i.e. only keeping Tat or Tat and His. All 
recombinant genes and the pairwise primers used in the PCR reaction are listed in Table 2. The 
ASKA plasmids were modified by PCR by using primers listed on Table 3. Initially, the 
corresponding ASKA plasmids hybA, torA, yedY, sufI, ycdO, cueO and ycdB were used as a template 
         P R         .      x m     Δ -ycdB (deleting of His tag sequence) was constructed from 
wildtype ycdB. The His-tag sequence coding His region was deleted by using the forward primer 
ASKA_delHis- (5' P GTG AGA TCC TCT CAT AGT TAA TTT CTC CTC 3') and the reverse 
primer ASKA_delHis+ (5' P aAT ACG GAT CCG GCC CTG AG 3') in the PCR. For all PCR the 
following conditions were used: hot start PCR, with initial 95°C for 5 minutes, then 40 cycles of 
95°C/ 1 minute, 55°C/ 1 minute and 68°C/ 10 minutes, with a final extension of 30 minutes at 68°C. 
Pfu Turbo DNA polymerase (Telongation 68°C) was used in order to avoid the errors of the Taq DNA 
polymerase, especially considering that the whole plasmid was amplified. Table 4 shows the PCR 
mixture prepared. The products of the PCR were checked on 1% agarose and the original template 
plasmid was removed by adding 2 µl of Dpn1 restriction enzyme (20.000 U/ml) to 45 µl of PCR 
products and incubating at 37 °C for 2.5 h. After this step the mixture was cleaned up by 
NucleoSpin
®
 Gel and PCR Clean-up kit. One µl of Roche T4 ligase (400.000 U/ml) was added to the 
DNA (26 µl) premixed with T4 ligase buffer 10X (3 µl) for overnight ligation at 16°C (in a PCR 
machine). A scheme to illustrate the PCR strategy for deleting these sequences is shown in Figure 6 
u     Δ -ycdB as an example. Recombinant genes were modified by PCR using identical protocols 
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with the corresponding templates and primer-pairs. The recombinant plasmids were checked by 
sequencing the insert using ASKA forward primer (5' GGC GTA TCA CGA GGC CCT TTC GTC 
TTC ACC TC 3'). A cartoon structure of these recombinant genes by deleting His, Tat, gene or any 
both are shown in Figure 7.  
Table 4. Components and concentrations of the PCR reactions. 
 Component Quantity (µl) Final concentration Notes on stock 
solutions 
1 ddH2O 25.5   
2 pfu buffer 5.0 1X 10X 
3 dNTPs 2.5 0.5 mM 10 mM 
4 DNA template (plasmid) 1.0 0.01 ~0.5 µg  
5 forward primer  6.0 0.3 µM 2.5 µM 
6 reverse primer 6.0 0.3 µM 2.5 µM 
7 DMSO 2.5 4% Additive to improve 
selective hybridisation 
of primers 
8 pfu polymerase 1.5  Added at the end 
 
 
Figure 7. Cartoon representing the structure of the recombinant ASKA genes with Tat signal sequence. The 
nomenclature used is specified on the right for each construct and the deleted part is labeled under every 
construct.  
3.1.3 Testing anti-silver ability of all recombinant genes  
We compared the anti-silver ability of each set of the 27 modified Tat-sequence containing plasmids 
with CysD as non-Tat containing positive control, by transforming the plasmids separately and 
picking single colonies from every strain according to the methods described in section 2.1.4. Briefly 
the cultures containing preculture, chloramphenicol and tetracycline in the presence of IPTG were 
incubated to OD600 0.4 at 37 °C, whereupon 6 µg/ml silver ion was added and incubated for 7 h at 
25°C. Samples were taken at 3.5 and 7 h followed by spreading 100 µl of 100×diluted culture to 
each plate. These plates were incubated for 24 h at 37 °C for colony-counting.  
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3.1.4 Analysis of periplasmic and spheroplastic recombinant proteins expressed in 
the presence of IPTG 
In order to detect the localisation of proteins encoded by Tat genes or their derivatives, enriched 
periplasmic and spheroplastic fractions were prepared with a Peripreps
TM
 Periplasting Kit. One 
milliliter (up to 2 OD600) of a fresh bacterial cell culture was taken and centrifugated in a 
m           u  .                          u   y    u           50 μ     P   P     P            
Bu            u          5 m  u          m   m     u  ;        50 μl of purified water at 4°C was 
added and mixed, incubating this mixture for 5 minutes on ice. Further, the lysed cells were pelleted 
by centrifugation in a microcentrifuge for 2 minutes at room temperature followed by transfer of the 
supernatant containing             m                        u  .                   u           100 μ  
   P   P     Ly    Bu          0.2 m /m  DNA   ; 1 μ     1.0       2 was added and mixed by 
inversion. This lysis buffer was incubated for 5 minutes at room temperature and cellular debris was 
precipitated by centrifugation in a microcentrifuge for 5 minutes at room temperature. Finally the 
 u                                                                            u       2 μ     500 m  
EDTA was added to chelate the magnesium. The periplasmic and spheroplastic fractions were 
analyzed by SDS-PAGE.  
3.1.5 Comparison of silver-resistance activity of Tat genes under anaerobic and 
aerobic conditions 
To explore the effect of oxygen on the anti-silver ability of Tat genes ycdB, cueO and torA, we 
investigated the effect of incubation of cells under anaerobic and aerobic conditions. First we 
transferred the plasmids containing three genes into XL1Blue cells and picked single colonies from 
every strain. The cultures inoculated were cultured at 37 °C with chloramphenicol and tetracycline in 
the presence of IPTG (1 mM). When OD600 of cultures reached 0.4, the culture was split in two. In 
one set, nitrogen was charged and 55 µg/ml metallic silver(0) added to one set of the pair. The other 
set of each culture was incubated in air in presence of the same concentration of metallic silver(0). 
All cultures, with and without oxygen were incubated for 8 h at 25 °C. Samples were taken at 
defined time intervals followed by spreading 100 µl of 100×diluted culture to each plate and 
incubating the plates for 24 h at 37 °C for colony counting. 
3.2 Results 
3.2.1 Selection of Tat genes with high resistance to silver ion 
An initial exploration of the growth of 27 strains upon IPTG induction, each strain containing a 
different ASKA plasmid coding for a gene with a Tat-signal, revealed that overexpression was 
apparently toxic in 5 different strains, as shown by lack of growth after 3 hr incubation. Therefore, 
only 22 different ASKA strains were tested further with 6 µg/ml silver ion. Amongst these strains, 
those expressing hybA, torA, yedY, sufI and ycdO showed most resistance to silver ion, as revealed 
by increased numbers of surviving colony-forming units (cfu) after 4 and 7 h of incubation with 
silver ion (Figure 8).  
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Figure 8. The resistance ability of strains with Tat genes to 6 µg/ml Ag
+
 after 4 and 7 h of incubation. The 
right red number is the times diluted for the culture and black number is the different Tat genes. 3-E. coli/hybA, 
7-E. coli/torA, 14-E. coli/yedY, 15-E. coli/sufI, 18-E. coli/ycdO, y-ycdB, e-empty. 
3.2.2 Confirmation of silver-resistance conferred by cysD and Tat genes 
                                                                                                                                                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. The resistance of strains with cysD and Tat genes to 6 µg/ml Ag
+
 after 7 h of incubation. (A) Bar 
graph of colony forming units (cfu) of all strains. (B) representative corresponding Petri dishes. Error bars 
represent means SD (standard deviation) from three replicates. 
The silver-resistance ability of the strains expressing tat-containing proteins was confirmed by 
comparison with cysD and ycdB controls, identified in the last chapter. Although after 3.5 h of 
incubation with silver ion all strains exhibited similar resistance (data not shown), clear differences 
in resistance were revealed at 7 h incubation with silver ion (Figure 9). Strains harbouring cysD, torA, 
yedY and hybA had more survivors upon incubation with silver ion than ycdB, which in turn had 
more survivors than cueO and ycdO. These latter strains, however, still gave more survivors than the 
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          u        “ m  y”     m    u             v         .          u  s confirmed the strong 
anti-silver ability of the selected gene cysD and, in addition, demonstrated that expression of some 
Tat genes also endow more resistance to silver.  
3.2.3 Testing of anti-silver ability of all recombined genes 
Many different TAT proteins conferred resistance to silver, which led us to ask whether Tat-
mediated export of the His-tag, which is a metal-binding motif and is expressed in all these 
constructs, could be involved in protection against silver. To answer this question we deleted the 
His-    (Δ -) of the 7 selected Tat genes and tested their silver-resistance (Figure 10A). The cfu of 
the original plasmids and those lacking the His-tag were similar for sufI, hybA, ycdO, torA and ycdB, 
indicating that His tag has little effect for these 5 Tat proteins. Deletion of the His tag of yedY and 
cueO led to increase in cfu, suggesting that the His-tag of both yedY and cueO hinders resistance to 
silver ion. These findings results indicated that the deletion of the his-tag in all the constructs tested 
either had little effect on resistance or actually increased resistance in the case of yedY and cueO.  
 
Figure 10. The resistance of recombinant strains to 6 µg/ml Ag
+
 after 7 h of incubation. Bar graph of (A) 
deleting of His-tag, (B) deleting of gene, (C) deleting of Tat signal sequence. (D) Petri dishes of original and 
recombinant genes of torA, ycdB and cueO. Error bars show standard deviations from three replicates. W-
     y    Δ -     u           ΔG-without       Δ ΔG -     u          &       Δ -without Tat sequence, 
Δ Δ -without His tag & Tat sequence.  
As controls, expression of just the Tat sequence alone or Tat sequence together with the his-tags of 
three selected genes (torA, ycdB, cueO) led to the elimination of resistance to silver and similar 
                        v                                “ m  y”     m    (Figure 10B and 10D). 
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These results support the notion that the silver resistance of these genes is conferred by the specific 
proteins expressed by the Tat-containing genes. We conclude, therefore, that resistance is related to 
gene function and not to the His-tag or Tat-sequences, either alone or in combination.  
Finally, we explored the effect of deletion of Tat alone or together with His-tag, i.e. expression of 
“m  u  ”                     u           qu           hybA, yedY, ycdO, torA, ycdB and cueO (the 
 v   x             Δ -sufI     Δ Δ -sufI are toxic to bacteria, so bacteria almost did not grow in 
the presence of IPTG). In most cases, there was a reduction of resistance as shown in Figure 10C: in 
particular deletion of Tat of hybA, yedY and ycdO decreased the number of cfu, most especially for 
yedY compared to corresponding wildtype. It is noteworthy that although deletion of Tat increased 
sensitivity of these strains to silver, their resistance was still above background, as determined by 
  m                 “ m  y     m  ”        .  u         y   n the case of torA and cueO, deletion of 
Tat had little effect on resistance; we hypothesise that these proteins may be co-transported to the 
periplasm in a complex with other Tat-exported proteins.
17
 For cueO deleting both Tat & His 
markedly increased silver-resistance, which suggests that the His tag interferes with expression or 
function of the gene-product (this trend is in line with the finding of increased silver resistance of 
Δ -cueO).  
3.2.4 Analysis of periplasmic and spheroplastic proteins encoded by Tat  
Proteins encoded by genes with Tat signal peptides can be transported by Tat pathway from 
cytoplasm to periplasm. To explore the effect of TAT deletion on protein expression and localisation, 
we carried out SDS-PAGE analyses on periplasmic and spheroplasmic fractions of TorA, CueO, 
YedY, and YcdB                  P   P    ™ P            K   (   u   11). SDS–PAGE analysis of 
Periplasmic and Spheroplastic proteins revealed different protein patterns, suggesting successful 
fraction-enrichment.  
For CueO, very strong overexpression was found in both fractions. CueO (and ΔH-CueO) showed 
two overexpressed species, especially evident in spheroplastic fractions, which corresponded to 
peptide-containing (58.404 KDa) and mature CueO (55.474 KDa). The presence of mature CueO 
existing in the spheroplastic part may simply be the result of translocon saturation: signal sequences 
of accumulating Tat substrates are often found to be sensitive to proteases, resulting in digestion of 
the signal sequence while the folded mature part of the protein remains intact. Accordingly, 
proteolytic degradation up to the mature folded domain is often cytoplasmically observed with 
recombinant Tat substrates in vivo when translocation becomes limiting, as described for YcdB.
15
 
For wildtype CueO, only an overexpressed species corresponding to mature CueO was found in the 
periplasm, but no pre-CueO was observed, which indicates purified periplasmic fractions, in which 
the 58.404 kDa precursor form of CueO of the cytoplasm is not present, but only the processed 
mature form with size 55.474 kDa. The protein level of CueO in the periplasm was relatively poor. 
This is possibly because the Tat system is slow and becomes rapidly saturated.
16
 Expression of ΔH-
cueO in the periplasm (mature protein only) was much weaker and only a weak faint band seen, 
indicating the His tag may play some role in the translocation of pre CueO from cytoplasm to 
periplasm. For ΔT-cueO and ΔTΔH-cueO, even with TAT deleted, abundant protein was found in 
the periplasm. This finding suggests that CueO can be exported to the periplasm independent of its 
own Tat sequence, perhaps by co-translocation with other Tat-containing proteins. We believe that 
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the presence of ΔT-CueO and ΔTΔH-CueO in periplasmic fractions is not just due to an artefact of 
the preparation such as spheroplasmic contamination, because in the wildtype control (and his-tag-
deleted fraction) only the spheroplasmic fraction contained a larger species corresponding to the 
“   -         ”    m         nal peptide. Comparing ΔT-CueO and ΔTΔH-CueO, the amount of 
both proteins was similar in spheroplasmic fractions, but recombinant ΔTΔH-CueO protein was less 
abundant than ΔT-CueO in the periplasm, also indicating that deletion of His-tag appears to affect 
expression and export, although such deletion leads to higher resistance. These results support the 
notion that the His-tag appears to interfere with the function and/or silver resistance of cueO. 
For YedY, recombinant protein was weakly expressed (in the spheroplastic fraction) and was not 
visible in the periplasm, suggesting that significant silver resistance was achieved with low protein 
levels. As for cueO, even with the deletion of Tat, the TorA protein was found abundantly in the 
periplasm (as well as in the spheroplasmic fraction). It is noteworthy that Tat deletion of torA led to 
higher expression both in spheroplastic and periplasmic fractions. However, visibly increased 
expression of recombinant protein in ΔT-torA did not correlate with increased resistance to silver 
(Figure 10C); we speculate that the presence of a Tat sequence or slow expression may be important 
for assembling a functional protein, for example aiding in cofactor binding. Similarly, Tat deletion 
of ycdB also led to higher expression and, as for TorA, even with the deletion of Tat, the 
recombinant protein was also found abundantly in the periplasm (as well as in the spheroplasmic 
fraction). For all proteins explored, deleting the Tat sequence gave much greater expression (Figure 
11), but this did no correlate with increased silver-resistance (Figure 10C). 
 
Figure 11. (A) SDS–PAGE analysis of Periplasmic and Spheroplastic proteins encoded by Tat genes. Pre 
(pre protein), Mat (mature protein), Molecular mass markers are indicated at the left. 1 CueO (58.404 KDa), 
2 ΔT-CueO (55.474 KDa), 3 ΔTΔH-CueO (54.475 KDa), 4 ΔH-CueO (58.319 KDa), 5 YedY (39.318 KDa), 
6 ΔT-YedY (34.569 KDa), 7 TorA (96.405 KDa), 8 ΔT-TorA (92.241 KDa), 9 YcdB (48.364 KDa), 10 ΔT-
YcdB (45.061 KDa).  
3.2.5 Comparing silver-resistance conferred by Tat genes under anaerobic and 
aerobic conditions 
ycdB, cueO and torA were tested for resistance to metallic Ag(0) under aerobic and anaerobic 
conditions. Both in aerobic and anaerobic conditions, all three strains had increased resistance to 
m        A (0)   m             “ m  y        ” (Figure 12). This cross-resistance to silver ion and 
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metallic Ag(0) supports the notion that both forms of silver exert their antimicrobial activity through 
common mechanisms. 
In aerobic conditions, the antimicrobial activity of metallic Ag(0) was increased compared to 
anaerobic conditions, as expected from the oxygen-mediated dissolution of nanoparticles, albeit only 
slightly. Metallic Ag(0) appeared to be antimicrobial in all cases tested and killed bacteria in a time-
dependent manner. In particular, no surviving colonies were fou           “ m  y”         u         
conditions tested after only 4 hr incubation, even in an anaerobic environment where metallic Ag(0) 
would be expected to be largely stable. This observation suggests that there may be an antimicrobial 
mechanism of metallic Ag(0), independent of the air-mediated oxidation and concomitant release of 
silver ions. Alternatively, we cannot discount the possibility that these metallic Ag(0) preparations 
also contained some contaminating Ag
+
, which could be the main antimicrobial agent in anaerobic 
conditions. ycdB, cueO and torA appear to be able to protect against both the silver ion-mediated 
killing and the postulated nanoparticle-selective mediated killing. torA expression conferred the most 
resistance to metallic silver, also in anaerobic conditions. It is noteworthy that the ratio of cfu in 
aerobic and anaerobic conditions differed between different strains (e.g. compare ycdB and torA in 
Figure 12) 
 
Figure 12. The resistance of strains expressing recombinant Tat-containing genes to 50 µg/ml metallic Ag(0) 
incubated at defined times under anaerobic and aerobic conditions. (A) Bar graphs of bacterial count surviving 
in the absence and presence of oxygen. (B) the corresponding Petri dishes after 6 h of incubation with 50 
µg/ml metallic Ag(0). 
3.3 Discussion 
YcdB is a periplasmic haem-containing peroxidase-like protein and CueO is multicopper oxidase 
required for copper homeostasis: both these Tat-containing proteins were described as conferring 
resistance to silver in Chapter 2. By screening strains expressing each of the identified Tat-
containing genes of E. coli for silver-ion resistance, we identified several genes -sufI, hybA, yedY 
and torA- which gave more resistance to silver ion than cueO. Of these, torA and hybA exhibited 
comparable resistance to silver ion to cysD (Figure 9), described at length in Chapter 2. The function 
of the 7 proteins encoded by Tat genes conferring most resistance to silver is listed simply in Table 5. 
Why do these Tat signal genes confer more resistance to silver? 
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SufI is structurally related to the multicopper oxidase superfamily, but analysis of the SufI sequence 
indicates that canonical copper-binding residues found in multicopper oxidases is almost absent: 
SufI is reported not to bind any copper and metal cofactors.
17
 SufI is a water soluble and monomeric 
protein, which does not require insertion of a cofactor during folding. The overall structure of SufI is 
very similar to that of CueO and contains three cupredoxin-like domains. A further difference 
between the CueO and SufI structures is the absence, in SufI, of the methionine-rich helix and loop, 
the so-called tower of the CueO structure. So SufI is neither a copper-binding protein nor an enzyme. 
A role for SufI is postulated to be protecting and stabilizing the divisional assembly under conditions 
of stress and to serve as a scaffolding protein that helps to maintain the coherence of the septal ring 
during constriction in cell division: i.e. the protein SufI (FtsP) of Escherichia coli has been 
recognized to be a component of the cell division apparatus. It has been reported that silver ions, 
besides their effects on bacterial enzymes and DNA, also caused marked inhibition of bacterial 
growth and were deposited in the vacuole and cell wall as granules.
17
 Silver inhibited cell division 
and damaged the cell envelope and contents of bacteria.
18
 Cell division was disrupted at the initial 
stage and caused the cells to undergo morphological changes and die at the later stage.
19 
However 
expression of SufI relieves the mytomycin C and paraquat sensitivity of division mutants, i.e. 
protects against radical-mediated damage,
20,21
 so can remedy the radical-mediated damage caused by 
silver ion. How this anti-radical activity of SufI is achieved is unclear, but it is in broad agreement 
with conclusions of Chapter 2, which supports the oxygen radical-mediated killing of silver and a 
concomitant mechanism of silver-resistance by preventing the generation of oxygen radicals. 
YedY was identified as the soluble periplasmic catalytic subunit of an oxidoreductase and contains a 
molybdo-molybdopterin cofactor. The overall fold of YedY is surprisingly similar to domain II of 
the eukaryotic chicken sulfite oxidase (CSO) and Arabidopsis thaliana sulfite oxidase (PSO). 
However, YedY shows a catalytic activity more in keeping with a reductase rather than a sulfite 
oxidase enzyme, because in YedY, only the IV and V states of molybdenum are attainable under the 
conditions reported.
22
 YedY functions as a reductase for substrates including trimethylamine N-
oxide (TMAO), Me2SO, phenylmethyl sulfoxide, methionine sulfoxide, and tetramethylene 
sulfoxide. The apparent one-electron capacity of YedY may be able to catalyze the reduction of S- 
and N-oxides. It is tempting to postulate that the anti-silver ability of YedY may arise from the 
reduction of Ag(I) to Ag(0) by the Mo (V). However, this hypothesis would need experimental 
testing.  
YcdO is also periplasmic, consisting of a C-terminal peptidase-M75 (M75) domain with a conserved 
‘ xxE’ m               y   v  v      m                    N-terminal domain that appears to 
resemble the copper-containing cupredoxins. The E. coli YcdO cup domain identifies two potential 
metal-binding sites. Site I is predicted to bind Cu
2+
 using three conserved residues (C41 and 103, and 
E66) and M101. Site II most probably binds Fe
3+
 and consists of four well conserved surface Glu 
residues. It is noteworthy that YcdO and YcdB appear to be organized in one operon with the gene 
ycdN. YcdB was also identified as conferring resistance to silver (see Chapter 2) and contains a 
noncovalent heme cofactor, which is assembled in the cytoplasm.
23
 The anti-silver ability of ycdO is 
weaker than for other Tat genes and cysD. We speculate YcdO may be binding the monovalent 
silver ion, perhaps through its recognised copper (II) and iron (III) binding sites, without any 
involvement of catalytic activity, thus explaining its low resistance-conferring ability. 
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The HybA protein participates in the periplasmic electron-transferring activity of hydrogenase 2 
during its catalytic turnover.
24
 Because structural and functional information is largely unavailable 
for this protein, we shall abstain from speculating on possible mechanisms of resistance to silver 
conferred by this HybA protein. 
The E. coli TMAO (trimethylamine N-oxide) reductase TorA is a soluble periplasmic enzyme 
containing the MGD (molybdopterin guanine dinucleotide) cofactor at its active site. TorA is a 
member of the DMSO reductase family of molybdoenzymes and the main respiratory enzyme 
responsible for TMAO reduction when the cells are grown anaerobically in the presence of 
TMAO;
25
 therefore TorA plays an important role in energy conservation under anaerobic growth 
conditions. The TorA protein is encoded by the torCAD operon. TorA is located in the periplasm 
and receives electrons from TorC. The acquisition of molybdo-cofactor is a prerequisite for TorA 
translocation.
25 
We speculate that the anti-silver ability of TorA may be similar to YedY, which also 
contains the molybdo-molybdopterin form of the molybdenum cofactor. Both these proteins are 
reductases that can reduce TMAO.  u O’   u                 y  xy   -dependent, even though 
expression of the cueO gene also occurred under anaerobic conditions.
26
 
All genes discussed in this chapter are Tat substrate proteins. At the beginning of this chapter we 
proposed the assumption that Tat signal sequence might play an important role in the resistance of 
proteins to silver ion. However, our results suggest that the Tat signal sequence only has small effect 
or no effect on anti-silver ability of these proteins. Silver resistance appears to be conferred by the 
activity of the proteins themselves (Figure 10), because expression of Tat or His-Tat alone did not 
lead to any significant resistance to silver compared to controls. However, Tat was not totally 
essential for export: especially for CueO and TorA, deletion of Tat did not affect export nor 
protection from silver. In all these proteins, deletion of Tat did not totally eliminate resistance, either 
because the recombinant proteins exert also a protective mechanism in the cytoplasm, but more 
likely because they are still partially exported (perhaps co-exported) even without Tat, a 
phenomenon that is well documented in the literature.
27
  
Table 5. The basic functions of the 7 Tat genes selected. 
Name Function Reference 
hybA Participates in the periplasmic electron-transferring activity of hydrogenase 2 during its catalytic 
turnover. 
28, 29 
torA Reduces trimethylamine-N-oxide (TMAO) into Trimethylamine; an anaerobic reaction coupled to 
energy-yielding reactions. 
29, 30 
yedY The exact function is not known. Can catalyze the reduction of a variety of substrates like dimethyl su 
lfoxide, trimethylamine N-oxide, phenylmethyl sulfoxide and L-methionine sulfoxide. Cannot reduce 
cyclic N-oxides. Shows no activity as sulfite oxidase. 
29, 31 
sufI Cell division protein that is required for growth during stress conditions. May be involved in protecting 
or stabilizing the divisomal assembly under conditions of stress. 
20, 21 
ycdO Involved in Fe2+  uptake. Could be an iron-binding and/or electron-transfer component. 29, 32 
cueO Probably involved in periplasmic detoxification of copper by oxidizing Cu+ to Cu2+ and thus preventing 
its uptake into the cytoplasm. Possesses phenoloxidase and ferroxidase activities and might be involved 
in the production of polyphenolic compounds and the prevention of oxidative damage in the periplasm. 
25,33 
ycdB Involved in the recovery of exogenous heme iron. Extracts iron from heme while preserving the 
tetrapyrrol ring intact. Also displays peroxidase activity on guaiacol in vitro. 
29, 34   
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3.4 Conclusion 
Our results demonstrated that expression of some Tat genes also endow more resistance to silver. 
Taken together, we conclude from the exploration of these recombinant Tat proteins by probing 
constructs with defined deletions for resistance to silver: 1) deleting the Tat signal sequence of genes 
has little effect on silver resistance, typically leading to marginally more susceptibility of the strains; 
however, these constructs typically expressed more recombinant protein, which was often still 
exported to the periplasm; i.e. the Tat signal sequence was not totally essential for export; 2) deleting 
the His tag of genes had little effect or actually increased resistance, thereby excluding the 
possibility that export of silver ions bound to the His-tag via the Tat pathway is a main mechanism 
of resistance; the His-tag sometimes affected expression and export of Tat proteins (e.g. for YedY 
and CueO); 3) deleting insert genes -expressing only Tat sequences with or without a His tag- 
drastically decreased the anti-silver ability of the host., i.e. the anti-silver ability of Tat genes was 
mainly from the insert genes but not from the His-tag or Tat-sequences, either alone or in 
combination. YcdB, CueO and TorA appear to be able to protect against both the silver ion-mediated 
killing and the postulated nanoparticle-selective mediated killing (which has, to our knowledge, 
never been demonstrated conclusively). The exact mechanism by which these enzymes exert their 
protective action against silver remains to be elucidated, although we believe that it may be mediated 
by their redox activities in the periplasm. It may be interesting to explore the resistance of bacteria 
expressing defined catalytic mutants of these enzymes. 
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Chapter 4   Directed evolution of genes for increased 
resistance to silver 
Introduction 
Previous chapters have described the identification of genes of E. coli whose recombinant 
overexpression leads to increased persistence in the presence of silver ion or nanoparticles. The goal 
of this chapter was to determine whether the silver-resistance function of some of these genes could 
be improved using directed evolution, as a means to gain insight into how resistance may function 
and evolve.  
Directed evolution is a method used in protein engineering, by which the process of natural selection 
to evolve proteins or nucleic acids are mimicked, typically on single genes, on a laboratory timescale, 
and by which special properties can be explored, which are not necessarily found in nature.
1-4
 For 
example, investigators have used directed evolution to improve or alter thermal and chemical 
stability where these specific traits are not apparent in the parent molecule,
5
 for novel protein-based 
tools and devices or to enhance the promiscuous activities of enzymes toward altered specificity.
6-10
 
The directed evolution process is based on the generation of mutant gene libraries, from which 
further improved mutants can be isolated by screening or selection assays. In directed evolution 
experiments creating molecular diversity is a crucial step. Routinely, diversity of proteins is now 
achieved by targeted or by random mutagenesis of the gene encoding an existing protein, either 
through altering the reaction conditions of standard PCR or through the use of error-prone DNA 
polymerases. The changed gene is introduced into a bacterial cell by transformation of a plasmid. 
This mutant gene produces the particular protein mutant.  
In this chapter, we chose 4 genes, which had been previously selected for resistance of AgNPs and 
silver ion in the absence and presence of IPTG, to conduct the directed evolution experiments in 
order to improve the anti-silver ability of these genes. The 4 genes chosen were ycdB, ydgT, and iscA 
(all originally selected without IPTG induction) and yeaO (selected with IPTG). Genes ydgT, yeaO 
and iscA conferred low resistance to silver, but barely above background, whereas ycdB conferred a 
little more resistance and was used to explore whether it is easy to improve further its anti-silver 
ability. In the experiments described in this chapter, random mutations were introduced into copies 
of ycdB, ydgT, yeaO and iscA genes by error-prone PCR. The mutagenized inserts were ligated into 
the expression vector modified pCA24N, which carries a chloramphenical resistance marker. 
Mutants with improved anti-silver ability were selected at the concentration of silver ion that identify 
mutants with enhanced resistance at LB medium supplemented with IPTG (Figure 1).  
The YdgT protein is an unkown protein and thought to be paralogue of Hha in E. coli.
11
 The Hha and 
YdgT proteins have been found to adjust the expression of horizontally acquired genes by interacting 
with H-NS and StpA, which play primary roles in the transcriptional silencing of such genes.
11
 
Overexpression of YdgT in hha mutants compensates at least partially some hha-induced phenotypes, 
in a similar way as it was described for the paralogue proteins H-NS and StpA. The interaction 
between Hha and H-NS families of proteins demonstrate that both Hha and YdgT are capable of 
generating heteromeric complexes with H-NS and StpA. Interaction of StpA with either Hha or 
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YdgT can also protect the former from Lon-mediated proteolysis.
12
 In our reasearch YdgT was 
chosen as the candidate of directed evolution only because it was present in many different clones 
during selection without IPTG (Chapter 2), although validation failed to show unequivocally 
whether it conferred increased resistance to silver.  
 
Figure 1. General strategy for directed evolution of genes conferring improved resistance to silver. 
IscA is a key member of the iron-sulfur cluster assembly machinery found in bacteria and eukaryotes. 
It can bind iron and [2Fe-2S] clusters, and participates in the biosynthesis of iron-sulfur proteins. 
IscA belongs to 110 amino acid residues long of scaffold proteins, which contain three conserved 
Cys residues in the sequence motif Cys-Xn-Cys-X-Cys (n=60–80), which are critical for Fe-S cluster 
binding and therefore its function. The Fe-S complexes of IscA are labile, and experiments in vitro 
have shown that clusters can be transferred from IscA (Fe-S) to apo-protein forms of other iron-
sulfur proteins.
13,14
 The function of IscA, however, is not well understood. IscA may act as an iron 
chaperone that delivers iron for the biogenesis of iron-sulfur clusters in IscU. Because IscA had been 
found in our preliminary selection experiments but conferred only very low resistance ability to 
silver, it was chosen for directed evolution. Finally, YeaO is a hypothetical protein with unknown 
structure and function. YeaO was chosen for directed evolution because it was selected with AgNPs 
and silver ion in the presence of IPTG, although it conferred very little, but detectable resistance to 
silver. 
4.1 Material and methods 
All chemicals were purchased from Applichem, unless otherwise specified. The polymerase and 
other restriction enzymes are ordered from New England Biolabs, unless specified. Modified 
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pCA24N, 4478bp, was used as the vector backbone, which includes two restriction sites NcoI 
(C/CATG/G) and NotI (GC/GGCC/GC). Forward primer Nco1 restriction site (5' A TTA ACC ATG 
GGA GGA TCT CAC CAT CAC C 3'), reverse primer (5' GGA GTT CTG AGG TCA TTA CTG G 
3') were synthesized from Microsynth, Switzerland and the gene sequencing was from Starseq, 
Germany.  
4.1.1 Creating a mutant library 
A single round of error-prone PCR was performed using the GeneMorphⅡRandom Mutagenesis Kit 
(Agilent technologies), which employs MutazymeⅡDNA polymerase (a blend of u   ym  І DNA 
polymerase and a novel Taq DNA polymerase mutant) that exhibits increased misinsertion and 
misextension frequencies compared to wildtype Taq. The combination of these two polymerases is 
thought to reduce bias and produce equivalent mutation rates at AT and GC sites, therefore 
promoting variation in the mutation type. 
The error-prone PCR reaction mixture (50 µl final volume) is comprised of: 41.5 µl of water, 5 µl of 
10× Mutazyme II reaction buffer, 1 µl of 40 mM dNTP mix (200 µM each final), 0.5 µl of primer 
mix (250 ng/µl of each primer), 1 µl of Mutazyme II DNA polymerase (2.5 U/µl), 1 µl template 
containing the DNA that was to be mutagenized. Forward primer Nco1 restriction site (5' A TTA 
ACC ATG GGA GGA TCT CAC CAT CAC C 3'), reverse primer (5' GGA GTT CTG AGG TCA 
TTA CTG G 3') were used. The amount of target DNA recommended by manufacturer here is 0.5-
1µg in order to gain low mutation rate (0-4.5 mutations/kb), so the amount of each plasmid template 
added should be calculated according to initial target DNA amount required for the mutation 
frequency desired. In the PCR reaction, all target DNA amount added were 0.5 µg. pCA24N vector
15 
 
(4478 bp). The target DNA ycdB was 392559 g/M, therfore the amount of plasmid ycdB added was 
0.5×(392559+1619925)/392559 µg. For ydgT, iscA and yeaO, the plasmids added were 
0.5×(64671+1619925)/64671 µg, 0.5×(98808+1619925)/98808 µg and 0.5×(105652+1619925) 
/105652 µg respectively. The error-prone PCR was run following the conditions: hot start PCR, with 
initial 95°C for 2 minutes, then 30 cycles of 95°C/1 minute, 56°C/1 minute and 72°C/2 minutes, 
with a final extension of 10 minutes at 72°C. The error-prone PCR product (2 µl) was run on an 
ethidium bromide-stained agarose gel alongside a DNA ladder. The remaining PCR product was 
digested to eliminate the template plasmids with DpnI (5 µl) for 5 h, and then the products was 
purified by PCR clean-up kit. The purified products were further digested with NcoI and NotI 
enzyme (µl) in NEBuffer 3.1 to prepare the insert genes. 
The modified pCA24N vector backbone (Derivative of pCA24N, where one T->C and A->G 
mutation places a NcoI (C/CATG/G) cloning site, producing cohesive ends. with Nco1/Not1 insertion 
from ASKA library) was used for the cloning and expression of error-prone library. In order to 
obtain the vector backbone, pCA24N was digested with NcoI and NotI enzyme in NEBuffer 3.1 in 1 
hour at 37°C. The insert genes and vector pCA24N digested were purified by PCR clean-up kit to 
ensure the ligation success. After that the insert mutagenesis library genes and vector pCA24N were 
ligated at a 5:1 molar with T4 DNA for 2.5 h at 37°C. After obtaining mutagenesis plasmid library 
we transformed this whole library into XL1-Blue with electroporation in order to get the libraries of 
mutant colonies for selection.  
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4.1.2 Selection of mutants with high anti-silver ability 
After obtaining the mutant bacterial library, we collected all colonies with LB medium (more than 
1000 colonies) and used pooled colonies as preculture. Further, the mutant colonies were selected 
according to methods described in previous chapters. Briefly, the cultures containing preculture, 
chloramphenicol and tetracycline (5 and 34 μ /m ) in the presence of IPTG were incubated to OD600 
0.4 at 37°C. Adding 7 µg/ml silver ion supplied as silver nitrate (to select the mutant genes with high 
anti-silver ability we increased the concentration of silver ion from 6 to 7 µg/ml) to OD600 0.4 ASKA 
strains and incubated the culture 7 h at 25°C. After 7 h of incubation with silver ion. 20 µl of culture 
was diluted 100 times, from which 100 µl spread on every plate. All the plates were incubated for 24 
h at 37 °C. Plasmids were purified from some of the resulting colonies, for re-transformation and re-
validation of the resistance to silver ion using 7 µg/ml of silver ion supplied as silver nitrate. The 
experimental process was the same as with the selection process, i.e. adding 7 µg/ml silver ion to 
OD600 0.4 ASKA strains and incubated the culture 7 h at 25°C. After 7 h of incubation with silver 
ion. Ten (10) µl of culture was diluted 100 times and 100 µl of this dilution was spread on every 
plate. All the plates were incubated for 24 h at 37°C. All picked colonies from the selected colonies 
were sequenced to check for mutations in the gene insert. In order to analyse the mutagenesis 
protocol, 10 colonies were also picked at random from media plates in absence of silver-selection 
and their gene inserts sequenced from the purified plasmids.  
After obtaining the mutants with high resistance to silver ion, we also examined resistance ability of 
these mutants to AgNPs and antibiotics. When 0.4 OD600 culture was obtained defined concentration 
of AgNPs and antibiotics were added into the culture and incubated for certain time at 25°C. Ten (10) 
µl of culture was diluted 100 times and 100 µl of this dilution was spread on every plate. 
4.2 Results 
In our directed evolution experiment, we wanted to improve the anti-silver ability of some genes by 
random mutagenesis of the gene. Mutagenesis and further selection of genes identified as conferring 
resistance to silver was designed to identify evolved mutants conferring further resistance to silver 
ion.  
Table 1 Mutations in the yeaO variants selected in the presence of 7 µg/ml silver ion. 
Mutant Amino acid change  Phenotypes 
1 Q118STOP ++ 
2 L131C -- 
3 T61M  and  L131F    -- 
4 L131F + 
5 K103R and Q118STOP - 
6 E82V -- 
7 C21F + 
8 K96T + 
9 F80V - 
'++' means more resistance than wildtype, '+' the same resistance as 
wildtype, '-' less resistance than wildtype, '--' much less resistance than 
wildtype. 14 colonies were sequenced, in which 9/14 were mutants and 
5/14 were wildtype. 
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For the yeaO mutant library    m                   y               7μ /m                            
of 9 mutants (Table 1), all of which had one or two non-synonimous point mutations. Mutant 1 
contained one premature nonsense mutation, which terminated the protein after 118 amino acids 
(13% of protein truncated). To confirm if these mutants of yeaO led to improved resistance to 
silver ion, a retransformation test was performed. We retransformed these mutant genes into 
XL1-Blue cell, then confirmed the improved phenotype of mutant strains by comparing them to 
that of T-yeaO (template-yeaO), W-yeaO (wildtype yeaO, i.e. the original ASKA plasmid) and 
M-pCA24N (modified empty pCA24N, the cloning vector used for this experiment) (Figure 2). 
This validation showed that, whereas some of the mutants performed worse than the wildtype, 
mutant 1 (Q118Stop-yeaO) conferred increased resistance compared to the original yeaO. 
Another truncated gene, containing mutations K103R & Q118Stop, did not render the host more 
resistant, and it appears that the conservative mutation K to R at residue 103 was deleterious for 
function (Figures 2 and 3). 
 
Figure 2. The resistance ability of yeaO strains to 7 µg/ml Ag
+
. Q118Stop-yeaO presents glutamine of yeaO 
was changed to stop codon by the er-PCR. T-yeaO represent template yeaO used in the er-PCR reaction. W-
yeaO is the wildtype yeaO from ASKA library. M-pCA24N is modified pCA24N. (left) bar graph and (right) 
Petri dishes of yeaO and vector strains after 4 and 7 h of incubation with 7 µg/ml Ag
+
. Error bars represent 
means the SD (standard deviation) from three biological replicates. 
T-YeaO             MGGSHHHHHHTDPALRANIQCKRVYDPAEQSDGYRILVDRLWPRGIKKTDLALDEWDKEI 60 
Q118STOP-YeaO      MGGSHHHHHHTDPALRANIQCKRVYDPAEQSDGYRILVDRLWPRGIKKTDLALDEWDKEI  
                   ************************************************************ 
 
T-YeaO             TPSTELRKAFHGEVVDYATFREQYLAELAQHEQEGKRLADIAKKQPLTLLYSAKNTTQNH 120 
Q118STOP-YeaO      TPSTELRKAFHGEVVDYATFREQYLAELAQHEQEGKRLADIAKKQPLTLLYSAKNTT-NH  
                   ********************************************************* ** 
 
T-YeaO             ALVLADWLRSLGLCGR 136 
Q118STOP-YeaO      ALVLADWLRSLGLCGR  
                   **************** 
Figure 3. Sequence comparision of the mature domains of T-YeaO (Template-YeaO) and mutant Q118Stop-
YeaO. The position of mutation is shown by red color and green color showed the position of mutation for 
lysine residue (to arginine) which occurred in mutant 5. The sequence underlined is artifical recombinant 
sequences introduced by the cloning strategy. 
Using the same approach as described above for yeaO random mutations were introduced into the 
template ydgT gene by error-prone PCR. After this mutant library was transformed into XL1-Blue 
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we picked some colonies from the mutants strain library for sequencing and 8 mutants were obtained 
which were shown in Table 2. For all mutants only one amino acid was substituted. A 
retransformation test was performed again to confirm the resistance of these mutants of ydgT to 
silver ion. Only mutant 4 of ydgT improved the anti-silver ability of original gene of ydgT while the 
other mutants decreased the resistance of ydgT to silver ion (Figure 4). The number of surviving 
clones upon selection in presence of silver ion of Q84H-ydgT was almost 5 times higher than for 
other control strains. This confirms the change of Q to H amino acid (Figure 5) improved the 
resistance of the ydgT to silver upon induction with IPTG.  
Table 2. Mutations in the YdgT variants selected in the presence of 7 µg/ml silver ion 
Mutant Amino acid change  Phenotypes 
1 Y39N -- 
2 D60A -- 
3 V67A -- 
4 Q84H ++ 
5 V67D + 
6 I53T + 
7 D21N -- 
8 H41L - 
 
'++' means more resistance than wildtype, '+' the same resistance as 
wildtype, '-' less resistance than wildtype, '--' much less resistance than 
wildtype. 25 colonies were sequenced, in which 8/25 are mutants and 
17/25 are wildtype. 
 
Figure 4. The resistance ability of ydgT strains to 7 µg/ml Ag
+
. Q84H-ydgT presents glutamine of ydgT was 
changed to histidine by the er-PCR. T-ydgT represent template YdgT used in the er-PCR reaction. W-ydgT is 
the wiltype ydgT from ASKA library. (left) bar graph and (right) Petri dishes of ydgT and vector strains after 4 
and 7 h of incubation with 7 µg/ml Ag
+
. Error bars represent means SD (standard deviation) from three 
biological replicates.  
For iscA, we picked some colonies from the iscA variant library to sequence. Twelve (12) mutants 
were identified (Table 3), all bearing a single nucleotide change. However, validation experiments 
by retransformation and reselection at 6 or 7 µg/ml Ag
+
 failed to detect variants with increased 
resistance compared to wildtype:  most of the mutants had less resistance than wildtype and only one 
had similar resistance. 
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A 
 
T-YdgT          MGGSHHHHHHTDPALRATVQDYLLKFRKISSLESLEKLYDHLNYTLTDDQELINMYRAA 60 
Q84H-YdgT       MGGSHHHHHHTDPALRATVQDYLLKFRKISSLESLEKLYDHLNYTLTDDQELINMYRAA  
                *********************************************************** 
 
T-YdgT          DHRRAELVSGGRLFDLGQVPKSVWHYVQGLCGR 93 
Q84H-YdgT       DHRRAELVSGGRLFDLGQVPKSVWHYVHGLCGR  
                ***************************:***** 
B 
                                
Figure 5. (A) Sequence comparison of the mature domains of T-YdgT (Template-YdgT) and mutant Q84H-
YdgT. The position of mutation is shown by red color and green color showed another histidine residue close 
to the position of mutation. (B) Chemical structure of a Ag(I)-m        “         -      ” (    17). The 
sequence underlined is artifical recombinant sequence introduced by the cloning strategy. 
 
Figure 6. Homology model of mutant Q84H-YdgT. The two views (A) and (B) are rotated 90° from each 
other. The two vicinal histidines, including the one at position 84 of the mutant right at the C-terminus of the 
model, are shown. This C-terminal region is thought to be flexible and is not thought to interfere with binding 
to the protein partner H-NS.
1 
The model is generated using the automated Swiss-Model software using the 
structure of the ortholog protein  hha as template (pdb:4ICG).  
Overall, in the 14 mutants sequenced 9 wildtypes were found. Although more mutants were acquired 
for iscA than ydgT and yeaO no single mutant was found that improved the anti-silver ability of iscA. 
These findings suggest that the function and activity of IscA protein may difficult to be enhanced 
only by one single round of error-prone PCR. Finally, we identified only two mutants of ycdB, but 
these also failed to confer enhanced anti-silver ability in validation experiments. No further mutants 
were identified upon sequencing several dozen unselected plasmids from this ycdB library, 
suggesting that the mutation efficiency was low for ycdB. 
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Table 3. Mutations in the IscA variants selected in the presence of 7 µg/ml silver ion 
Mutant Amino acid change  Phenotypes 
1 G3E -  
2 M54T -- 
3 M54K + 
4 Y56C -- 
5 P66L - 
6 G45D - 
7 S49F - 
8 I19T - 
9 V76M - 
10 L33Q - 
11 I19T - 
12 F106L - 
'++' means more resistance than wildtype, '+' the same resistance as 
wildtype, '-' less resistance than wildtype, '--' much less resistance than 
wildtype. 21 colonies were sequenced, in which 12/21 are mutants and 
9/21 are wildtype, others were disordered. 
Table 5. Mutations in the ycdB variants selected in the presence of 7 µg/ml silver ion 
Mutant Amino acid change  Phenotypes 
1 S4Y and Q275A -  
2 Y19C - 
 
'++' means more resistance than wildtype, '+' the same resistance as 
wildtype, '-' less resistance than wildtype, '--' much less resistance than 
wildtype. 4 colonies were sequenced, in which 2/4 are mutants and 2/4 
are wildtype. 
Mutants Q118Stop-yeaO and Q84H-ydgT have improved resistance ability to silver ion, so we 
further tested the resistance of these two mutants to AgNPs and antibiotics (Figure 7). By 
comparison it can be seen these two mutants Q118Stop-yeaO and Q84H-ydgT also have improved 
resistance to 200 µg/ml of AgNPs (Figure 6A and B). However the results of resistance of these two 
to antibiotics (ampicillin and kanamycin) did not show improved resistance compared to control 
(Figure 6C). This indicated that mutants evolved by silver ion can also give resistance to different 
silver compounds –i.e. to silver nanoparticles- but that increased resistance to silver does not 
necessarily lead to increased resistance to antibiotics. 
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Figure 7. The resistance ability of yeaO and ydgT strains to AgNPs and antibiotics. (A) bar graphs of 
resistance of two mutants to 200 µg/ml of AgNPs after 3.5 h of incubation. (B) corresponding Petri dishes of 
resistance of two mutants. (C) The resistance ability of yeaO and ydgT strains to 10 and 15 µg/ml of 
kanamycin and 30 and 35 µg/ml of ampicilin. 1 w-yeaO, 2 Q118Stop-yeaO, 3 w-ydgT, 4 Q84H-ydgT, 5 M-
pCN24N. Error bars represent means SD (standard deviation) from three biological replicates.  
4.3 Discussion 
I      1970’  O     y                duplication underlines molecular evolution of new functions,16 
since after duplication one gene would be entirely redundant and freed from all constraints, to either 
become a nonfunctional pseudogene in most cases, with little loss of fitness for the organism, or to 
evolve a new function with a concomitant gain of fitness. In this chapter, we aimed to improve the 
anti-silver resistance function of yeaO, ydgT, iscA and ycdB.  
In our directed evolution experiment, on the basis of Ohno's hypothesis, first we selected for silver 
resistance conferred by copies of genes of E. coli borne by a plasmid –with the original gene 
maintained in the chromosome of the host. Further mutation and selection of the plasmid-borne 
genes was then made possible, thus evolving for a new activity without loss of original function of 
the chromosomically-encoded gene. Although this directed evolution was laboratory-based, we 
suggest that it may have parallels with wh   m y                     “    ”       x m     u     
selection pressure imposed by use of antimicrobial silver in clinical environments. 
We found that the anti-silver resistance of yeaO and ydgT could be improved by single amino-acid 
replacement mutation or truncation of the genes. For yeaO, only the nonsense mutant Q118STOP-
yeaO was found to improve resistance to silver, whereas another truncated mutant with K103R 
mutation failed to show improved resistance. The reason why the nonsense mutant Q118STOP-yeaO 
can improve the anti-silver ability is still very difficult to predict without further structural and 
biochemical information. The protein yeaO is currently labeled as “hypothetical protein”         
structure and function are not known.  
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For the mutants of ydgT, the Q84H (Figure 5) substitution conferred enhanced silver-resistance. 
Histidine is an amino acid containing an imidazole side-chain and it is widely recognized that Ag
+
 
can bind to imidazoles
17,18
 and that the moderate Ag(I)-N bonding property may play an important  
role in showing the wide spectra of antimicrobial activities of silver.
19
 Silver(I) atom is known as a 
soft Lewis acid and has a relatively low affinity for hard oxygen donors, high affinities for soft 
donors S and P, and moderate affinities for nitrogen donors, and it usually forms two- or four-
coordination complexes.
20
 For the bonding ability of silver(I) atom, some experiments in ligand-
exchange reactions have suggested the relative order of strength to be: Ag(I)-S >> Ag(I)-C1 > Ag(I)-
N >> Ag(I)-O.
21
 It is of interest that the newly-introduced histidine in the mutant Q84H is close to 
another histidine residue, in what may be a flexible region at the C-terminus of this small protein 
(Figure 6). Taken together, we speculate that the two histidine residues of mutant Q84H-YdgT may 
coordinate silver ions by the two imidazole motif. However, since histidine-tag overexpression 
appears insufficient to confer increased resistance to silver, the Q84H mutation of YdgT may also be 
increasing the biological function of this protein.  
In contrast to YdgT and YeaO, we did not find any mutants of YcdB and IscA conferring increased 
resistance to silver. For ycdB, only got very few transformants were obtained and larger libraries 
should be tested. We conclude from the experiments with iscA, where comparable libraries to ydgT 
and yeaO were obtained, that it may be challenging to select for improved variants. The protein 
encoded by iscA is a key member of the iron-sulfur cluster assembly machinery and participates in 
the biosynthesis of iron-sulfur cluster proteins. Most mutations that we explored led to increased 
susceptibility to silver, indicating that the anti-silver ability of iscA is difficult to improve. 
Measurement of mutants Q118Stop-yeaO and Q84H-ydgT to AgNPs and antibiotics verified that 
these two mutants have cross resistance to silver ion and to AgNPs, but not to antibiotics. This result 
is encouraging because, despite the finding that resistance to silver can correlate to resistance to 
antibiotics (see chapter 2), it suggests that this dependency is not absolute and that evolution of 
silver-resistance does not necessarily lead to increased resistance to antibiotics.  
4.4 Conclusions 
Evolution is a very powerful and useful design strategy. In this chapter we improved genetically the 
silver resistance conferred by two plasmid-encoded genes by laboratory evolution. We reach two 
main conclusions: first, our facile proof-of-concept evolution of two genes for silver ion or 
nanoparticle resistance suggests that silver-resistance may also evolve easily outside the laboratory, 
such as in hospitals or other environments; indeed, we suggest that low level resistance by 
overexpression of defined genes initially conferring low-level resistance (e.g. due to duplication or 
plasmid-encoded multicopy) offers a first step toward the evolution of increased resistance, whether 
in the laboratory or in the wild. Second, evolution of silver-resistance in these two gene-variants did 
not correlate to increased antibiotic resistance. This latter finding offers hope that widespread use of 
antimicrobial silver will not hinder necessarily the urgent fight against antibiotic resistance. On the 
contrary, the evolved variants discovered could even prove of practical interest, for example in their 
potential future applications in recombinant bacterial strains for the purposes of bioremediation. 
Further to the proof-of-concept of evolution of resistance to silver described here, more work will be 
needed to explore the structure and function of mutants and to elucidate the mechanism by which 
they confer their resistance to silver.  
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Chapter 5    Summary and Outlook 
With the rising incidence of antibiotic resistance and the emergence of new virulent pathogens, there 
is a growing need to enhance our antibacterial arsenal. This is particularly imperative for infections 
caused by Gram-negative bacteria.
1-3
 Silver is known as a board spectrum antibacterial agent. 
Despite this long-standing history and its demonstrated activity against Gram-negative bacteria, the 
complete bactericidal mode of action of silver remains unclear. In order to research these issues, we 
first identified anti-silver genes, including cysD and ycdB, by selection in presence of silver ion or 
nanoparticles of E.coli expressing the ASKA plasmid library, which comprises each open reading 
frame of the genome of this bacterium. The cysD gene not only gave more resistance to kinds of 
silver compounds but also rendered cells more resistant to Cu
+
 and Cd
2+
.
 
Silver ions and 
nanoparticles were more toxic in aerobic than anaerobic conditions, suggesting that nanoparticles 
can release toxic silver ions, a view that is reaching an increasing consensus in the field. Assays for 
production of hydroxyl radicals also support the notion that toxicity is mediated through reactive 
oxygen radicals (ROS) and that prevention of ROS production is involved in the acquisition of 
resistance. We also tested the resistance of cysD and ycdB expression to the antibiotics kanamycin 
and ampicillin as well as synergistic function of antibiotics and silver. Our results suggest that anti-
silver genes can also give rise to resistance to antibiotics. However, we also found that kanamycin 
and silver act synergistically and that the combination of both compounds tremendously improved 
the antibacterial activity of both antimicrobial agents; in contrast, such synergism was not observed 
between ampicillin and silver. Our search for genes conferring silver resistance uncovered a 
surprising array of proteins, some of uncharacterised. The finding that overexpression of several Tat-
exported proteins, most particularly TorA, led to considerable silver-resistance points toward redox 
processes within the periplasmic space of Gram-negative organisms being crucial to the 
antimicrobial activity of silver. Finally, we provide proof-of-concept using directed evolution of two 
different genes (ydgT and yeaO) that increased silver resistance is evolvable from low-level 
resistance by incorporation of point mutations. This finding illustrates that anti-silver mutants could 
potentially be obtained also in hospital or any other environments where there is selection pressure 
due to silver toxicity. However, in the case of ydgT and yeaO, increased resistance to silver did not 
correlate with increased resistance to kanamycin nor ampicillin. This latter preliminary observation 
offers the hope that increasing use of silver in consumer and medical products will not necessarily 
contribute to antibiotic resistance. 
The work presented here, however, leaves many open questions, including: 
 Do nanoparticles contribute to toxicity in the absence of silver ion production? Although all 
evidence points toward ionic silver being the main toxic species, it remains unclear whether 
silver nanoparticles themselves contribute at all to toxicity. We were unable to find any gene 
whose overexpression led to resistance to any one particular form of silver alone, e.g. 
resistance to nanoparticles alone or resistance to silver ion alone. The finding of generalized 
cross-resistance further supports that silver ion and silver nanoparticles share a common 
mechanism of toxicity. 
 Stoichiometric or catalytic? We speculate that the low-level resistance of the ydgT mutant 
harbouring an additional histidine, may be due to direct binding to silver, a hypothesis that 
requires further structural and biochemical exploration. However, the finding that several 
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proteins expressed at low level contribute to considerable silver resistance, such as cysD and 
ycdB, points toward the existence of catalytic mechanisms of resistance, rather than simply 
via direct silver-coordination. Supporting this view is the observation that expression of his-
tag, whether alone or fused to a tat-signal peptide, was insufficient to confer significant 
resistance to silver. It may be interesting to explore the resistance of bacteria expressing 
defined catalytic mutants of these enzymes. 
 How does cysD confer resistance to silver? In our hands, expression of cysD led to most 
silver resistance, although it was expressed at low levels. Nevertheless, we found that 
extracts of the cysD expressing strain did not have increased levels of thiols, as could be 
expected from its involvement in cysteine metabolism. However, quantification of hydroxyl 
radical production suggested that both the cysD and ycdB expressing strains had lower levels 
of reactive oxygen species (ROS) than equivalent controls, although they showed no 
increased resistance to hydrogen peroxide. Together, these observations suggest that 
prevention of ROS generation, possibly mediated through protective sulfur-containing 
compounds, may lead to increased resistance to silver. Here, metabolomic profiling of the 
various strains could prove informative. 
 What is the role of redox processes in silver toxicity? Exposure to silver led to increased 
ROS production, which correlated with increased bacterial killing. However, exactly how 
ROS were generated remains unclear. At first glance, oxidation of Ag(0) to Ag
+
 requires a 
loss of an electron, which may lead to oxygen radical generation. From this point of view, it 
may not necessarily be the nanoparticle or the ion per se that is the toxic species, but rather 
the radical generated. However, further investigation makes it clear that it is the most soluble 
silver salts that are the most toxic of any silver species tested and, moreover, we found that 
silver ion itself led to the generation of ROS.
4
 However, how does silver ion lead to 
increased generation of ROS? Is silver itself participating in redox processes, or is it 
replacing other bound metal species, such as copper or iron, which can then participate in 
Fenton-like processes? The finding of cross-resistance of cysD and ycdB expressing strains 
to Cd
2+
 suggests the latter. 
 What is the role of redox processes in silver resistance? As noted above, expression of cysD 
and ycdB led to lower levels of ROS and increased resistance. Several of the genes selected, 
particularly the Tat-signal encoding genes, are reported to encode enzymes that catalyze 
redox chemistries. Therefore, there is an emerging picture that prevention of radical 
formation may lead to increased resistance to silver. However, how is this putative 
prevention of ROS formation achieved, exactly? Is it through quenching radical species? Is 
it through stabilization of toxic metals to redox-inert species or through formation of 
metallic silver through reduction of silver ion? Could some of the strains of E. coli described 
here be forming silver nanoparticles? What is the main oxidized species in the postulated 
silver ion-m                  m    y                       “             ”     u              
in resistant hosts? 
 What is the physiological function of the genes identified to confer silver resistance? For 
several of the genes found, the structure and function remain unknown. For example, 
virtually no information on structure and function is available for yeaO. However, 
expression of a mutant of this hypothetical protein with a premature stop codon (leading to a 
 76 
truncated protein 18% shorter) conferred markedly increased resistance to silver. Clearly, 
further structural and biochemical data are required. 
 Why does the silver and kanamycin combination lead to such synergy in antimicrobial 
action (but not silver and ampicillin)? Could this finding be clinically useful? Are there other 
such synergisms with potential to lead to better antibiotic treatment? 
 What is the mechanism by which silver resistance also confers increased resistance to 
antibiotics? i.e. why do the cysD and ycdB expressing strains, which have lowered 
production of ROS, have increased MIC for ampicillin and kanamycin? Do these findings 
support a role for a radical-mediated action of antibiotics, a very topical and much-debated 
issue? What about resistance of strains to other antibiotics? 
 If increased resistance to silver in strains harbouring ycdB and cysD plasmids led to 
increased resistance to antibiotics, why did mutants of yeaO and ydgT, which conferred 
increased resistance to silver compared to the wildtype, not lead also to increased antibiotic 
resistance? 
 Do the mechanisms of silver resistance described here bear any resemblance to potential 
resistance outside of laboratory settings, for example in clinical settings where silver is used 
for antimicrobial purposes? Could mechanisms of resistance discovered in the laboratory, 
such as the ones described here, be engineered for the purposes of bioremediation, for 
example? 
 
In summary, the work described offers a novel approach, namely exploration of bacterial 
resistance to silver in a laboratory setting, that sheds new light on the mechanisms of silver 
antimicrobial action. This research contributes to fundamental aspects of the biochemistry 
and evolution of bacteria and, finally, provides glimpses of possible future practical 
applications, for example in antibiotic research, in the biocatalytic synthesis of nanoparticles 
or in bioremediation. 
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